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Carotid artery elasticity has become a commonly assessed non-invasive marker of 
arterial health that is relatively easy to administer (Chirinos et al., 2012; Hoeks et al., 
1990; Hoeks et al., 1999; Riley et al., 1992; Tardy et al., 1991) compared to other arterial 
health measures (Charakida et al., 2010; Corretti et al., 2002; Deanfield et al., 2005; 
Harris et al., 2010; Thijssen et al., 2011). Indeed, the loss of elastic properties within the 
larger and more elastic arteries like the carotid artery contributes substantially to the 
increase in systolic blood pressure as well as pulse pressure, which are known 
independent risk factors for the development of cardiovascular disease (Menotti et al., 
1989; Safar et al., 2003). Such risk factors can lead to compensatory remodeling of the 
carotid artery and nearby arterial beds, as well as create synergistic detriments to the 
arterial tree in the presence of other risk independent risk factors (Benetos et al., 2002; 
Giannattasio et al., 1996; Humphrey, 2002; Lakatta, 2003; Laurent et al., 1993; Nichols 
et al., 1993; Nichols & O’Rourke, 1998). 
Decreased carotid arterial elasticity and increased stiffness has been reported with 
advanced aging in both men and women (Arnett, Evans, & Riley, 1994; Mitchell et al., 
2004). However, little research has examined artery elasticity measures in otherwise 
healthy adults with special focus on potential sex differences. Additionally, little research 
on arterial elasticity and stiffness has been conducted in children and adolescents. 
Specifically, while no studies have examined arterial elasticity throughout puberty, 
cardiovascular and metabolic changes throughout puberty indeed occur (Amiel et al., 
1986; Bloch & Clemons, 1987; Caprio et al., 1994; Caprio & Tamborlane, 1994; Cook et 
al., 2003; Goran & Gower, 2001; Moran et al., 1999; Richards et al., 1992; Sinaiko et al., 
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2001; Travers et al., 1995; Uwaifo et al., 2002) and may influence vascular structure, 
mechanics, and function. Specifically, increased insulin resistance associated with 
pubertal onset and subsequent recession following maturation (Moran et al., 1999) may 
influence arterial elasticity. Based on the available literature, the purpose of the following 
dissertation was to both perform a cross-sectional examination of the potential influence 
of sex, pubertal development, and age, on measures of carotid arterial elasticity in 
otherwise healthy children, adolescents, and adults, to lend additional insight to the 
already existing body of research surrounding arterial elasticity and stiffness.  
Given vascular dysfunction is considered an early manifestation of atherosclerosis 
(Celermajer et al., 1992; Deanfield et al., 2007), potential therapeutic remedies that 
dampen cardiovascular risk in populations that are at increased risk for vascular 
dysfunction are critical to explore. Childhood cancer survivors are one such population at 
increased risk of cardiovascular disease compared to otherwise healthy individuals, with 
survivors having reduced carotid artery elasticity compared to healthy sibling controls 
(Dengel et al., 2014). Furthermore, HMG coenzyme A reductase inhibitors, or statins, are 
widely used for cardiovascular disease risk reduction (Stone et al., 2013). Specifically, 
atorvastatin has been shown to improve endothelial function independent of reducing 
cholesterol (Reriani et al., 2011), as well as reduce arterial stiffness and slow arterial 
thickening in multiple populations (Orr et al., 2009; Ratchford et al., 2011), yet the 
effects of atorvastatin have never been evaluated in childhood cancer survivors. 
Therefore, the therapeutic effect of atorvastatin on carotid arterial elasticity in adult 
survivors a childhood cancer was further evaluated within the present dissertation. 
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The specific study aims arising from this dissertation are as follows: 
1. Evaluate the influence of pubertal development on carotid artery elasticity in 
healthy children and adolescents. 
a. Hypothesis 1: Carotid arterial elasticity and stiffness will differ by pubertal 
stage in accordance with associated changes in cardiometabolic risk factors. 
Specifically, carotid elasticity will be lowest among Tanner stages II-IV 
compared to Tanner stages I and V. 
2. Evaluate differences related to sex and age on carotid arterial elasticity in healthy 
children and adults. Also evaluate whether a relationship exists between brachial 
and carotid arterial elasticity in a subset of participants with both measures. 
a. Hypothesis 1: Carotid arterial elasticity will differ by sex and differences will 
become more apparent with age. Additionally, an association between brachial 
and carotid arterial elasticity may exist. 
3. Evaluate the ability of 6-months of atorvastatin treatment to improve carotid artery 
elasticity in a randomized trial of adult survivors of childhood cancer. 
a. Hypothesis 1: Compared to placebo, atorvastatin will increase carotid arterial 
elasticity and reduce carotid stiffness in adult survivors of childhood cancer. 
The second chapter of this dissertation will provide an extensive review of the 
existing literature on arterial elasticity. Arterial wall properties related to vessel elasticity 
and stiffness, and methodologies commonly used to quantify carotid artery elasticity and 
stiffness will be described. Additionally, risk factors associated with carotid arterial 
elasticity and stiffness will also be discussed. 
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 The third chapter will examine the influence of pubertal development on carotid 
arterial elasticity in a healthy sample of children and adolescents. Insulin resistance is 
commonly associated with pubertal onset in childhood and adolescents, with insulin 
levels returning to near pre-pubertal status following maturation. Moreover, the potential 
impact of insulin resistance on vascular health is evaluated. 
 The influence of sex on carotid arterial elasticity in healthy children and adults, 
and the potential relationship to brachial arterial elasticity, will be examined in chapter 
four. Few studies have examined differences between the sexes in both children and 
adults, and no studies have examined the relationship between brachial and carotid 
arterial elasticity and stiffness. Indeed, systemic versus regional differences in arterial 
elasticity is important to examine.  
 The fifth chapter will evaluate whether 6-months of atorvastatin therapy, 
compared to placebo, can elicit improvements in carotid artery elasticity and stiffness in a 
population of young adult survivors of childhood cancer. Atorvastatin has been shown to 
improve endothelial function independent of reducing cholesterol, as well as reduce 
arterial stiffness and slow arterial thickening in multiple populations, yet has never been 
studied in childhood cancer survivors. Given childhood cancer survivors are at higher 
risk for cardiovascular disease compared to an otherwise healthy population, safe and 
effective methods of improving vascular healthy are explored here. 
 And finally, a summary of each study and pertinent observations will be reviewed 
in chapter six. Future research surrounding arterial elasticity will be proposed. 
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Introduction 
Over the last several decades, there has been great interest in the early detection 
of and progression to cardiovascular disease (CVD) in order to prevent future 
cardiovascular events. Consequently, non-invasive assessment of vascular health is 
currently employed to assess arterial wall properties to provide a preclinical marker of 
cardiovascular risk and subclinical atherosclerosis (Barenbrock et al., 2002; Blacher et 
al., 1998; Laurent et al., 2001; Leone et al., 2008). Indeed, peripheral vascular function as 
commonly assessed by brachial artery reactivity testing via flow-mediated dilation 
(FMD) correlates well with coronary artery endothelial function (Anderson et al., 1995; 
Takase et al., 1998) and quantifies the functional capacity of the vascular endothelium; 
however, while the principle of FMD appears simple, its application is technically 
challenging and requires extensive training and standardization (Charakida et al., 2010; 
Corretti et al., 2002; Deanfield et al., 2005; Harris et al., 2010; Thijssen et al., 2011). 
Conversely, non-invasive imaging of the common carotid artery is often easier to 
administer and can lend to the identification of central vascular dysfunction and therefore 
improve risk stratification (Flammer et al., 2012). Besides being used to diagnose 
atherosclerotic lesions, imaging of the carotid artery is commonly used to assess intima-
media thickness (IMT). Certainly, carotid IMT is a parameter used in epidemiological 
(Bots et al., 1997; O’Leary et al., 1990) and intervention studies (Boutouyrie et al., 2000) 
as an indicator of atherosclerotic disease (Simon et al., 2002).  
More recently, the focus of non-invasive imaging of the carotid artery has been on 
the assessment of arterial wall properties related to elasticity and stiffness, specifically 
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vessel distension, circumferential strain, compliance, distensibility, as well as Young’s 
modulus via conventional ultrasound imaging (Chirinos et al., 2012; Hoeks et al., 1990; 
Hoeks et al., 1999; Riley et al., 1992; Tardy et al., 1991). Other techniques have been 
further employed to quantify relative degrees of arterial stiffness, such as pulse wave 
velocity and aortic pulse wave analysis (Nichols, 2005; O’Rourke et al., 2001). 
Understanding these dynamic parameters is important because the loss of elastic 
properties within larger elastic arteries like the carotid artery, as in aging (Reneman et al., 
1985; Reneman et al., 1986) and in borderline (Van Merode et al., 1988; Van Merode et 
al., 1993) and essential hypertension (Laurent et al., 1994; Laurent, 1995), contributes 
substantially to the increase in systolic blood pressure as well as pulse pressure, which 
are known independent risk factors (Menotti et al., 1989; Safar et al., 2003). Indeed, 
arterial stiffness also increases with other disease states, such as diabetes mellitus, 
obesity, smoking, hypercholesterolemia, and kidney disease (Payne et al., 2010).  
 The following literature review will describe arterial wall properties related to 
vessel elasticity and stiffness, and methodologies commonly used to quantify carotid 
artery elasticity and stiffness. Risk factors associated with carotid arterial elasticity and 
stiffness will be discussed. Furthermore, this review will identify the need for extended 
carotid artery elasticity and stiffness research in children and adult populations, as well as 
present a case in which individuals at higher risk for CVD mortality, specifically 
childhood cancer survivors, may be ideal candidates for treatment specific therapy that 
improves structural and mechanical properties of elastic arteries like the carotid artery. 
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Arterial Wall Properties Related to Elasticity and Stiffness 
The Windkessel model of the arterial system is the oldest arterial model to date 
(Westerhoff et al., 2009). The concept arose from old-fashioned fire engines that 
transformed pulsatile flow from a steam or hand-activated pump into a steady water 
stream through the fire hose nozzle. In such a model, the origin of the flow represents the 
cushioning function of the arteries, particularly the aorta that acts as an elastic reservoir, 
and the nozzle represented peripheral resistance (Nichols & O’Rourke, 1998). Indeed, the 
Windkessel effect of an elastic aorta helps to dampen fluctuations in blood pressure (or 
pulse pressure) over the cardiac cycle, keeping pressure relatively constant despite the 
pulsatile nature of blood flow, and therefore assists in the maintenance of organ perfusion 
during diastole when cardiac ejection ceases. Although conceptually useful, the 
Windkessel model is unrealistic given elastic properties are distributed all along the 
arterial tree and not just confined to the aorta. Physical properties of arteries are different 
as well, with different arterial sites responding differently to aging, hypertension, and 
drugs (Bank & Kaiser, 1998; Boutouyrie et al., 1992). Therefore, the mechanical and 
arterial properties of the arterial system need to be understood in order to fully 
comprehend measures of arterial elasticity and stiffness at different arterial sites.  
 
The Stress-Strain Relationship of the Arterial System 
The major elastic arteries of the body exhibit a stress-strain relationship that 
allows them to react to blood flow demands and resist overstretching. The stress-strain 
relationship of the arterial system (synonymously referred to as the pressure-strain, 
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pressure-volume, or pressure-diameter relationship), details the stretch capacity of elastic 
arteries such as the common carotid artery. Indeed, mechanical forces and the resulting 
induced deformations on particular materials have been extensively studied for over three 
centuries. The classic physics of elasticity is said to have started in 1600 with the 
discovery by Robert Hooke who stated relationships between mechanical stress and strain 
in isotropic materials, within their elastic limit, are constant. In physics, stress is the 
internal distribution of forces within a body that balance and react to the external loads 
applied to it, while strain is defined as the mechanical (fractional) deformation of a 
physical body under the action of applied forces or deforming stress. The standard 
definition of Robert Hooke’s law implies that bodily exposures to these stresses exhibit a 
linear-elastic relationship, or “Hookean.” 
Indeed, the stress-strain relationship is a critical component of arterial elasticity 
and stiffness and is thus essential to the understanding of pathophysiological mechanisms 
in the vascular bed. Within an arterial vessel, stress is the intensity of the force applied 
across a plane (or arterial wall) expressed as units of force per unit area. Hemodynamic 
conditions inside the blood vessel lead to the development of superficial stresses near the 
vessel walls. Specifically, three distinct stressors exist within blood vessels: (1) 
circumferential (direct) stress due to the pulse pressure (PP) variation inside the vessel 
itself, (2) shear (indirect) stress applied to the vessel wall due to the increase in blood 
flow through the vessel following ventricular contraction, and (3) axial wall stress that 
arises during development and persists into maturity due to the long half-life of elastin 
(Dobrin et al., 1990; Humphrey, 2008; Papaioannou et al., 2005). Conversely, with 
   11 
respect to an arterial vessel, strain is the relative increase in vessel volume (or the more 
easily measured diameter change) produced by that force.  
Given the diverse molecular and mechanical composition of blood vessels, 
however, arterial walls are not Hookean (Nichols & O’Rourke, 2005). Interestingly, only 
a few biomaterials truly approximate Hookean behavior, like wood and skeletal bone. 
Instead, arteries are naturally pre-stressed due to previously noted axial wall stress and 
therefore even the minimum blood pressure must be sufficiently positive to raise blood to 
the highest point of the body. The somewhat neutral position of a healthy artery 
demonstrates the presence of constant low tension. As a result, the stress-strain 
relationship is usually represented by a continually upward sloping J-shaped curve (Fig. 
1). Initially, small increases in stress (or pressure) produce large relative changes in 
diameter; however, an elastic artery becomes stiffer and more difficult to distend at larger 
strain levels and thus requires larger stresses to elicit larger strains (Chirinos et al., 2012). 
 
Figure 1. Stress-Strain Relationship of an Elastic Artery 
 
 
Adapted from the University of Cambridge DoITPoMS 
(Online Tutorial titled ‘Elasticity in Biological Materials’) 
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Stress loading and unloading occurs along the same curve and thus, the loading is 
completely reversible in a healthy artery with little to no vascular remodeling. A healthy 
elastic artery maintains that all energy used in dilatation is returned once the load is 
removed to ensure smooth variations in blood pressure and blood flow. Moreover, normal 
blood pressure, and subsequently PP, and shear stress are transferred to the heterogeneous 
arterial wall layers (i.e., intima, media, and adventitia) and regulate blood vessel diameter 
depending on the elasticity and physiologic function of the individual vessels. Of course, 
the proportions of these arterial wall layers differ along the arterial tree. 
 
Differences Along the Arterial Tree 
 
Wall Properties 
Findings over the past few decades have revealed the larger (elastic) arteries 
emerging from the heart (i.e. aorta, pulmonary artery, brachicephalic trunk, common 
carotid artery, and subclavian) have different vessel wall structure compared to the more 
distal (muscular) branching arteries like the brachial, radial, and femoral arteries, and 
thus respond markedly different to altered stimuli. Indeed, the proportional layering of 
wall properties such as smooth muscle, elastin, collagen, and fibroblasts is critical to the 
homeostasis of the vascular wall and thus, the arterial proportions of these properties 
along the arterial tree is important to consider when assessing vascular function and 
subsequently comparing one arterial bed to another. 
While the more central (elastic) arteries contain more elastin and less smooth 
muscle, collagen, and connective tissue components, peripheral arteries tend to contain 
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just the opposite. Additionally with age, the amount of elastic fibers decreases while 
collagen increases throughout the arterial tree. Amongst the many effects of aging on 
arteries, including increased endothelial dysfunction and advanced glycation endproducts 
(Lakatta et al., 2009; Safar, 2010), it appears that fatigue-type damage to elastic fibers is 
particularly important (Arribas et al., 2006; O’Rourke & Hashimoto, 2007). Still, the 
exact pathophysiological and temporality of arterial stiffening is not fully understood 
(Tsamis & Stergiopulos, 2007). 
Differential remodeling can even occur within vessels of the same general 
classification and within close proximity to one another. In response to hypertension, all 
arteries and arterioles tend to thicken, yet the elastic arteries, muscular arteries, and 
arterioles tend to do so while increasing, maintaining, and decreasing their caliber (or 
luminal diameter), respectively (Humphrey, 2002). Sparing of the peripheral arteries has 
been reported previously (Benetos et al., 1993; Gillessen et al., 1995). Specific to the 
larger, more elastic arteries, an increase in diameter may be due to compensation for 
decreases in aortic elasticity (Benetos et al., 1993; Reneman et al., 1985) and attempts of 
the more elastic vessels to maintain relatively low impedance while maintaining pressure 
and stroke volume. Furthermore, dilatation of the aorta or common carotid artery is often 
accompanied by geometric changes in the left ventricle indicating the presence of 
cardiovascular coupling (Boutouyrie et al., 1995). 
The ascending aorta is suggested as being the first central artery to manifest aging 
related structural changes that affect overall mechanical properties (Redheuil et al., 
2010), and has thus surrogate measures of aortic function are valuable indicators of 
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arterial health. Indeed, both the aorta and common carotid artery are close in proximity 
and demonstrate similar remodeling techniques compared to the more peripheral arteries 
(Boutouyrie et al., 1992). Interestingly, there exists the possibility that increased 
susceptibility of the ascending aorta to an aging related losses of elastic fiber integrity 
may explain in part the increased in susceptibility of the same region to dilatation and 
dissection in Marfan syndrome (Pearson et al., 2008), which results from a genetic 
mutation in the fibrillin-1 gene. While fibrillin-1 appears to help stabilize elastic fibers, 
mutations result in decreased elastic fiber integrity.  
 
Hemodynamic Stress 
The pulse pressure wave following ventricular contraction also changes shape 
within the different vascular beds. Ventricular contraction creates both arterial blood flow 
and a pressure wave that propagates a pulse along the arterial tree. Not to be confused 
with blood velocity, ‘forward moving’ pulse pressure waves relate to the transmission of 
energy through the arterial wall. Indeed, the speed of pulse wave transmission largely 
exceeds blood velocity in the aorta to minimize arterial damage due to longitudinal shock 
waves and turbulent flow if blood flow velocity exceeded pulse wave velocity 
(O’Rourke, 2006). As the pulse pressure wave form moves distally along the arterial tree, 
peripheral resistance increases as a result of reduced vessel diameter towards arteries that 
are comprised of less elastic fibers and, subsequently, an amplification in PP occurring 
and directly changes the shape of the forward moving pressure wave. Indeed, systolic 
pressure rises and diastolic pressure falls (thus, increase in PP) as the pressure pulse 
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travels away from the aorta (O’Rourke et al., 2001).  
Conversely, ‘reflective’ waves, or the forward pulse pressure wave reflections, 
can be initiated at multiple sites along the arterial tree because of changes in vessel wall 
properties (e.g. elasticity, stiffness, vasomotor tone) or in the architecture of the artery 
itself (e.g., branching points, calcifications). In young subjects, the backward (reflective) 
pressure wave returns from the distal arterial compartment during diastole, making PP 
higher in peripheral than in central arteries (Nichols & O’Rourke, 1998). The resulting 
combination of both the forward and reflective waves (‘augmented’ wave) indeed 
represents a surrogate aortic measure of structure and mechanics of the vessel wall. 
 
Arterial Elasticity 
Given the increased understanding of the distinct wall properties and pressure 
differences along the arterial tree, arterial elasticity has become an increasing focal point 
in the past decade and is associated with CVD (Fjeldstad et al., 2008; Havlik et al., 2003). 
Elasticity, by definition, is the ability of a body or material to return to its previous shape 
after a deforming force or stress is released. Three common measures of arterial elasticity 
are compliance, distensibility, and elastic modulus. 
 
Compliance, Distensibility, and Elastic Modulus 
Compliance, by definition, is the absolute change in volume (∆V, strain) induced 
by a change in pressure (∆P, stress), or the absolute change in arterial volume that reflects 
the arterial ability to store volume and thus reducing increases in pressure during left 
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ventricular ejection (Jani & Rajkumar, 2006; Reneman et al., 2005). Given arterial length 
does not change substantially due to longitudinally tethering of arteries at their in vivo 
length (L’Italien et al., 1994; Patel & Fry, 1966), an artery should distend via increases in 
diameter with increases in intra-arterial pressure. Since arterial volume is difficult to 
accurately measure in vivo, a change in arterial volume is often substituted for changes in 
diameter (∆D) or vessel cross-sectional area. Together with systemic vascular resistance, 
compliance is considered the major determinant of afterload (Levy et al., 1990). 
Although compliance is influenced by the material properties of the arterial wall 
layers (Bank et al., 1996; Farrar et al., 1978; Roach & Burton, 1957), compliance is not a 
direct index of wall stiffness because the measure is affected by arterial size and wall 
thickness. As the law of Laplace states, circumferential wall stress is directly proportional 
to the vessel radius and the luminal pressure and inversely proportional to the wall 
thickness and, thus, increased luminal diameter or decreased wall thickness is 
proportional to circumferential wall stress and luminal pressure. Therefore, variability 
between arteries (and individuals) via arterial size and wall thickness need to be 
accounted for because of the influence pressure-strain relations, pressure-volume, and 
pressure-diameter relationships for any given stiffness of the wall material. Indeed, 
arteries with thicker walls will have lower compliance than those with thinner walls, 
provided identical elastic properties of the wall material. Similarly, larger arteries will 
have larger compliance for identical wall material properties and relative geometry (wall 
thickness-to-wall ratio) than smaller arteries. As a result, compliance should be 
normalized for initial arterial volume when comparing arteries of a different size. 
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Distensibility incorporates the relative change in arterial volume (∆V/V) against the 
change in pressure (∆P), or the mechanical load or stress placed on the arterial wall 
(Reneman et al., 2005), and thus reflects normalized compliance. Distensibility tends to 
relate more closely to wall stiffness due to its relativeness to initial volume (V).  
Another measure of arterial elasticity is an incremental elastic modulus (Einc), or 
synonymously referred to as Young's modulus. Because the stress-strain relationship of 
an elastic artery is a non-linear J-shaped curve, the tangential slope of the curve provides 
direct information on the intrinsic elastic properties of the arterial wall independent of 
vessel geometry. Whereas small PP increases initially produce a larger relative increase 
in vessel diameter in a healthy elastic artery, the non-linear J-shaped stress-strain curve 
tends to shift up and left in an adapted hypertensive state (Fig. 2); thus, a greater 
tangential slope demonstrates that a greater PP is necessary to produce the same relative 
change in vessel diameter – the hallmark of a stiffer artery (Tsamis & Stergiopulos, 
2007). The elastic modulus is inversely proportional to cross-sectional area as it relates to 
∆P. Indeed, a more elastic vessel will lend to a decreased tangential slope. 
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Figure 2. Effect of Hypertension on the Stress-Strain Relationship 
 
 
Adapted from the University of Cambridge DoITPoMS  
(Online Tutorial titled ‘Elasticity in Biological Materials’)  
with reference to Tsamis & Stergiopulos (2007)  
 
Non-Invasive Ultrasound Imaging of Arterial Elasticity 
Two critical measures are required to compute arterial elasticity. First, the change 
in arterial diameter (∆D), or the surrogate measure of arterial volume, is required. And 
second, local blood pressure at the assessed artery is needed to calculate ∆P (or PP). 
Changes in arterial diameter (distension) can be assessed via conventional ultrasound 
imaging and wall-tracking techniques, tissue Doppler imaging, or magnetic resonance 
imaging (MRI) (Herment et al., 2010; Meinders & Hoeks, 2004; Redheuil et al., 2010; 
Vermeersch et al., 2008). While MRI imaging is particularly useful to assess the 
distension of deeper arteries (i.e. aorta), conventional ultrasound imaging technology is 
often used in subclinical populations as a well-accepted non-invasive measure. Blood 
pressure, and subsequently PP, is also required to compute measures of arterial elasticity. 
Specifically, ∆P should be determined at the same site at which arterial elasticity 
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measurements are performed.  
Standard practice of collecting carotid artery images is to concurrently measure 
carotid artery diameter as well as supine systolic and diastolic blood pressure and PP with 
subjects in the supine position following a bout of quiet rest. Over a 10-sec period, 20 
frames per second are collected (200 frames) at a fixed position approximately 1 cm 
proximal from the carotid artery bulb. Mean luminal systolic and diastolic diameters, as 
well as a concurrent brachial artery blood pressure, are recorded during the 10-sec carotid 
assessment and then used to calculate measures of carotid compliance and distensibility. 
Due to variability of PP amplification between the central carotid artery and the brachial 
artery, brachial PP is not equivalent to carotid, aortic, or radial PP (or PP in any other 
distant artery) (Nichols & O’Rourke, 2005). Indeed, using brachial PP as a surrogate 
measure of carotid PP is a distinct limitation; however, it is common limitation among 
non-invasive assessment of carotid elasticity. 
Within the context of the following dissertation, we will be referring to the 
following formulas for the quantification of arterial elasticity parameters: 
Table 1. Measures of Arterial Elasticity 
Measurements Formula Comments 
Diameter Compliance 
(DC, mm/mmHg) ∆D / ∆P 
↑DC ~ 
↑Elasticity 
Cross-Sectional Compliance 
1 (CSC1, mm2/mmHg) [(π*(Dmax/2)
2 - π*(Dmin/2)2)/(∆P)] ↑CSC1 ~ ↑Elasticity 
Cross-Sectional Compliance 
2 (CSC2, 1/mmHg) 
[(π*(Dmax/2)2 - 
π*(Dmin/2)2)/(π*(Dmin/2)2*∆P)] 
↑CSC2 ~ 
↑Elasticity 
Diameter Distensibility 
(DD, %) [∆D / Dmin] x 100% 
↑DD ~ 
↑Elasticity 
Cross-Sectional Distensibility 
(CSD, %) 
[(π*(Dmax/2)2 - 
π*(Dmin/2)2)/π*(Dmin/2)2] x 100% 
↑CSD ~ 
↑Elasticity 
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Incremental Elastic Modulus 
(IEM or E, mmHg) 
3{1+[π*(maxDiamM/2)2/ 
π*(minDiamM/2)2]} / CSC1 
↑IEM ~ 
↓Elasticity 
∆D, change/difference in arterial diameter at systolic and diastolic pressures; ∆P, difference 
between systolic and diastolic pressures; Dmax, maximum diameter; Dmin, minimum diameter.  
 
While distensibility is the relative change in diameter (∆D/D) relative to the ∆P 
during the cardiac cycle, the following dissertation describes diameter distensibility as the 
relative change in diameter without the influence of ∆P, and thus describes simply the 
‘distention’ of the artery. Additionally, the variations in elasticity calculations should be 
carefully considered when comparing the results of different studies. 
 
Arterial Stiffness  
Arterial stiffness, another measure of vascular wall mechanics, directly impacts 
the ability of the arteries to accommodate the blood ejected by the ventricles without 
imposing an excessive afterload (Chirinos & Segers, 2010a; Chirinos & Segers, 2010b; 
Nichols & O’Rourke, 2005; Segers & Verdonck, 2002). Stiffness is resistance offered by 
an elastic body to deformation, and can be measured with several methods depending on 
the clinical use or experimental situation. In clinical practice, arterial stiffness can be 
non-invasively estimated by three principal methodologies: (1) pulse transit time for 
evaluation of the pulse wave velocity, (2) the analysis of the arterial pressure wave 
contour, and (3) the direct stiffness estimation using measurements of diameter or arterial 
luminal cross-sectional area and distending pressure measured at the site of diameter 
changes, as previously described as arterial elasticity (Karamanoglu et al., 1993; Laurent 
& Boutouyrie, 2006; Van Bortel & Seger, 2006). Indeed, the two most frequently used 
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stiffness methods are measurement of pulse wave velocity (PWV) and central (aortic or 
common carotid artery) pulse wave analysis. 
 
Pulse Wave Velocity 
Pulse wave velocity is often regarded as the in vivo “gold standard” index of 
arterial stiffness (Laurent et al., 2006). Due to its independence of both the stress-strain 
relationship and wave reflection, PWV is also considered a very robust index of stiffness 
(Asmar, 2000; Bramwell & Hill, 1922; Nichols & O’Rourke, 1998) yet is strongly 
dependent on current blood pressure and heart rate. As PWV increases from the aorta 
towards the peripheral arteries, this rapidly propagated pressure gradient moves distally 
along the arterial tree resulting in almost immediate downstream mobilization of blood in 
the arterial system (Vlachopoulos et al., 2010), and therefore is a functional parameter 
directly affected by arterial wall stiffness, as well as other factors including geometry (i.e. 
thickness h, radius r), the intrinsic elastic properties of the arterial wall (i.e. incremental 
elastic modulus, E), and blood density (ρ). The first relationship was formulated by 
Moens and Korteweg that PWV=√Eh/2rρ (O’Rourke, 2006). Later, Bramwell and Hill 
described the association in terms of distensibility (D), which is determined by the blood 
vessel’s compliance (C): PWV=1/√ρDC, and moreover that higher PWV corresponds to 
lower vessel distensibility and compliance, and therefore to a higher arterial stiffness.  
The forward traveling pulse wave is commonly assessed between two recorded 
(paired) sites in the line of pulse travel, and the delay between the ventricular ejection and 
initial upstroke of the pulse wave at each site is the point of reference for PWV 
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quantification (Asmar, 2000). While PWV can be measured at the level of peripheral 
arteries, carotid-femoral (‘aortic’) PWV is the most relevant because the aorta is the 
principal ‘cushioning’ artery and is responsible for the pathophysiological effects of 
arterial stiffening and its association with cardiovascular morbidity and mortality in 
hypertensive patients, type 2 diabetes, end-stage renal disease and in elderly populations 
(Hansen et al., 2006; Kullo et al., 2006; Laurent et al., 2006; Pannier et al., 2005; Tillin et 
al., 2007). Yet while aortic PWV is considered the gold standard of the paired sites 
(Laurent et al., 2006), femoral measurement can be tough to administer due to the 
physical location and ability to generate a confident pulse wave index. As such, carotid-
radial techniques are often employed in substitution (as in the proposed dissertation) 
albeit usual limitations (Salvi, 2012). 
 
Aortic Pulse Wave Analysis (PWA) 
Recent studies have shown that central aortic blood pressure, the pressure exerted 
on the heart, brain, and kidneys, is a better predictor of CV risk than brachial blood 
pressure (Chirinos et al., 2005). Consequently, analysis of aortic waveform and 
amplitude, or aortic pulse wave analysis, is another frequently used method to assess 
large artery properties and eventually arterial stiffness. As a pressure wave moves 
through the arterial tree, it encounters impedance resulting in a reflected wave that moves 
back toward the heart, and thus augments (i.e. amplifies) peak systolic pressure. The 
amplification of the PP is due to greater stiffness of peripheral arteries and enhanced 
wave reflection amplitude, which depends on the difference between elastic moduli of the 
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respective arteries and distance to major reflecting sites (Nichols & O’Rourke, 2005). As 
a result, these two pulsatile blood pressure components are greater in arteries of the 
extremities than in the central aorta. As stiffness increases, reflected wave amplitude 
increases and augments pressure in late systole, or in worse cases early systole, producing 
an increase in afterload and myocardial oxygen demand. The term augmentation index 
(AI) has been coined to showcase the relationship in aortic amplitude.  
 
Applanation Tonometry Assessment of PWV and Aortic PWA 
Recently, several technologies have been proposed to record non-invasive 
pressure waveforms and apply signal processing to derive arterial wave contour 
parameters. One technique is the reliable recording of pressure waves by arterial 
applanation tonometry. Indeed, applanation tonometry has been widely validated and 
allows for the estimation of systolic and diastolic blood pressures, of form factor (an 
indicator of pulse wave shape), and of the AI, an index of all systemic reflection waves at 
the site of assessment. 
The forward traveling pulse wave is commonly assessed between two recorded 
sites in the line of pulse travel, and the delay between the R-wave and initial upstroke of 
the pulse wave at each site is the point of reference for PWV quantification (Asmar, 
2000). Subsequently, the pressure gradient transit time (t) and distance (D) as measured 
over the body surface between paired pulse wave sites is determined. Paired comparisons 
of the forward traveling pulse wave are assessed to provide a D/t relationship at the 
carotid-femoral, carotid-radial, or (less so) at the carotid-ankle sites (Laurent et al., 2006; 
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Sugawara et al., 2005; Tillin et al., 2007). Regardless of paired site, subtracting the 
proximal D and t site measurements from distal measurements, respectively, and then 
generating the composite PWV for the paired sites can be used to calculate PWV.  
 Conversely, aortic pulse wave analysis can be quantified at both the carotid and 
radial artery sites, resulting in separate aortic AI measures at each site, via the transmitted 
pulse wave at the relevant site. Given mean arterial pressure is relatively constant 
throughout the arterial tree, applanation tonometry uses brachial blood pressure to 
calibrate and non-invasively estimate ascending aortic pressure wave forms from both the 
carotid and radial arteries via a patented transfer function (Karamanoglu et al., 1993). The 
ascending aortic waveforms are then averaged into a single calibrated wave whose 
different features can be identified automatically with clinically important measures of 
pressure and time intervals. Indeed, aortic AI estimation at the radial site is known to be a 
more reliable measure than AI assessment at the carotid artery (Kelly et al., 1990). Apart 
from some uncertainty of calibrating carotid artery blood pressure from mean pressure 
via the brachial pressures, carotid tonometry requires considerable expertise due to the 
artery being deep in the neck. Additionally, the carotid artery is not easily applanated due 
to frequent respiration and swallowing artifact given the technique is often uncomfortable 
(O’Rourke & Adji, 2010). Conversely, radial applanation is easier to administer given the 
superficial nature of the radial artery as well as the bones and tendons that lay posterior 
that aid in the applanation of the artery. 
Calculated from baseline resting pulse waves, site-specific AI values represent the 
relative contribution of augmented pressure due to wave reflection to the pressure 
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waveform. Proprietary software automatically identifies inflection points distinguishing 
the systolic peak (P1) and the reflected peak (P2) for the calculation of this ratio and 
converts it into a percentage (P1-P2/P1*100). Because AI is inversely related to heart 
rate, values are sometimes mathematically adjusted to represent arterial stiffness at a 
standard heart rate of 75 beats per minute (AI@75); however, standard unadjusted AI is 
often sufficient when heart rate is not different across or between multiple measurements. 
As such, AI and PWV are not interchangeable indices as determined by cross-sectional 
and longitudinal studies (Cecelja et al., 2009; Cecelja et al., 2012). AI depends not only 
on arterial stiffness per se (reflected by PWV) but also on other parameters, such as the 
pattern of ventricular ejection, the vascular tone, or the absolute systole duration 
(Lantelme et al., 2002). 
 
Limitations of Arterial Elasticity and Stiffness Assessment 
There are indeed limitations to using non-invasive assessment for quantifying 
arterial elasticity. First, using changes in vessel diameter (and not changes in volume) 
when calculating elasticity assumes that vascular distention is due to radius changes and 
not arterial lengthening, as well as that the vascular cross section is perfectly circular. 
Second, brachial PP is not necessarily equivalent to carotid, aortic, or radial PP, and thus 
using brachial PP as a surrogate measure of carotid PP is not ideal. Third, there are 
indeed intrinsic problems with characterizing arterial elasticity due to the complexity of 
the arterial system, including the non-linear nature of an artery and the gradual shift in 
wall parameters that make identifying the same physiologic point in all study participants 
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rather difficult. Thus, measurement of arterial properties at one segment of the arterial 
tree does not necessarily assist in the interpretation of changes at other points 
(Giannattasio et al., 1996; Nichols & O’Rourke, 1998). Additionally, characterizing 
patients with distended or dilated aortas (as in Marfan syndrome), or even patients whose 
central arteries have dilated via compensatory remodeling, may have greater compliance 
relative to a much lower distensibility (Nichols & O’Rourke, 1998). And finally, while 
not necessarily a limitation per se, differing formulas are used throughout the literature 
when calculating measures of elasticity, making direct comparisons across studies more 
difficult. Indeed, while non-invasive assessment showcases these limitations, such non-
invasive assessments are critical for early detection of vascular dysfunction whilst more 
invasive techniques are more cumbersome and indeed more expensive. 
 Several limitations exist when quantifying vessel stiffness as well. One obvious 
limitation of PWV is the determination of actual arterial distance between recording sites 
via measurements above the skin surface. Another PWV limitation, specific to carotid-
radial quantification, is the fact that the carotid and radial arteries are not in the direct line 
from the aorta and thus incorporate more diversified vascular properties (O’Rourke & 
Mancia, 1999; O’Rourke et al., 2002). Subsequently, using brachial artery blood pressure 
to calibrate radial and carotid pulse waves for quantification of augmentation index is 
also not ideal (Smulyan et al., 2003). Use of a generalized transfer function assumes that 
properties of the arterial system between the two sites are the same in all persons under 
all conditions (O’Rourke et al, 2001). Indeed, the output error (at the aorta) is associated 
with the input errors at the radial artery attributable to both the under- or over-estimation 
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of actual (intraarterial) systolic and diastolic pressures, depending on which noninvasive 
method is applied (Smulyan et al., 2008), as well as the presence of brachial-to-radial 
pressure amplification (Nichols & O’Rourke, 2005; Verbeke et al., 2005). 
 
Risk Factors Associated with Arterial Elasticity and Stiffness  
Despite the large number of studies indicating that elevated levels of 
cardiovascular risk factors are related to decreased vessel elasticity and increased 
stiffness, the pathophysiological and temporal mechanism of stiffening of the arteries is 
not fully understood. There are several risk factors, specifically age and hypertension 
(Benetos et al., 2002; Cecelja & Chowienczyk, 2009), which are more confidently 
associated with arterial elasticity and stiffness.  
 
Age 
Increasing age is associated with worsening arterial elasticity properties in both 
men and women, and may be an independent cardiovascular risk factor (Benetos et al., 
1997; Franklin et al., 1999; Laurent et al., 2001; Madhavan et al., 1994; Smulyan et al., 
2001). While some research suggests a linear relationship between arterial stiffness and 
age (Avolio et al., 1983; Avolio et al., 1985), others have found accelerated stiffening 
between 50 and 60 years of age (Benetos et al., 2002; Franklin et al., 1997; Lajemi et al., 
2001; McEniery et al., 2005). Indeed, the effects of aging are different on proximal, 
predominantly elastic arteries compared with distal, predominantly muscular arteries 
(Avolio et al., 1985; Benetos et al., 1993; Nichols & O’Rourke, 1990; Nichols et al., 
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2008), which may lend to differences in age-related effects. More central arteries like the 
aorta and common carotid arteries stiffen progressively with age, whereas stiffness of 
muscular arteries changes little with age (Benetos et al., 1993; Mitchell et al., 2004; 
O’Rourke et al., 2002; Reneman et al., 1985). Additionally, larger artery compliance 
likely decreases due to both a pronounced decrease in arterial distensibility and with an 
increase in diameter (Benetos et al., 1993; Reneman et al., 1985). Again, increases in 
diameter with aging (9% increase in central artery luminal diameter per decade from 20 
to 60 years in the ascending aorta) might be due to compensation for the decrease in 
elasticity in order to limit a decrease in compliance (Lakatta, 2003). More distal arteries 
like the radial and femoral artery in otherwise healthy subjects have been reported to not 
decrease in elasticity with age, possibly due to compensatory loss of elasticity in the more 
elastic arteries (Laurent et al., 1993).  
As previously discussed, the aorta and common carotid arteries are also subject to 
age-related structural remodeling in both the tunica media and intima layers. Within the 
media specifically, fracturing of elastin and increases in collagen and calcium deposits 
occur with age likely as the result of repeated cyclic stress (Johnson et al., 2001; 
O’Rourke & Hashimoto, 2007). Predominant changes within the intima include increase 
in intima-media thickness and prevalence of atherosclerosis. Interestingly, histological 
examination of the intima of stiffened vessels reveals abnormal and disarrayed 
endothelial cells, increased collagen, frayed and broken elastin molecules, infiltration of 
vascular smooth muscle cells, macrophages and mononuclear cells, and increased matrix 
metalloproteinases, transforming growth factor (TGF)-β, intracellular cell adhesion 
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molecules, and cytokines (Lakatta, 2003). Remodeling of both the intima and media 
layers result in decreased elasticity and increases in stiffness via PWV (Avolio et al., 
1983; Cecelja & Chowienczyk, 2012).  
Interestingly, infants have remarkably similar arterial pulse wave contours (and 
amplitudes) as the elderly. Specifically, amplitude in both central and peripheral arteries 
is low with no secondary wave in diastole and the peak wave is seen in late rather than 
early systole (Hsieh et al., 1989; Nichols & O’Rourke, 1998; O’Rourke et al., 1992). 
With progression to adolescence, however, peripheral pulse amplifies compared to 
central pulse, with the peak moving into early systole with the secondary diastolic wave 
apparent in early diastole, and is accounted for by the marked increase in peripheral PP 
and systolic pressure during adolescence (Uiterwaal et al., 1997), as well as the relatively 
long left ventricular ejection period despite small body size and faster heart rate (Hsieh et 
al., 1989; Nichols & O’Rourke, 1998). The short body length in infants, despite the aorta 
being very distensible and having relatively low PWV, showcases a similar amplitude 
and wave contour as elderly, whose higher PWV is due to increased stiffness. 
 
Hypertension 
 Increasing systolic blood pressure paralleled with a lack of change or decrease in 
DBP is another common culprit of elasticity deterioration and increased stiffness with 
aging (Benetos et al., 2002; Kannel et al., 1981; Liu et al., 1989; Safar et al., 1984; 
Staessen et al., 1990) with the subsequent increases in PP and increased afterload (due to 
early reflective pulse waves) likely affecting cardiovascular risk factors and contributing 
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to vascular damage over time as well as reduced perfusion of the coronary arteries in 
diastole (Darne et al., 1989; Fang et al, 1995; Madhavan et al., 1994; Nichols & 
O’Rourke, 1998). Sustained, chronic hypertension is strongly related to increased arterial 
stiffness (Amar et al., 2001; Benetos et al., 1993; Liao et al., 1999; Safar et al., 1987) by 
induction of structural changes, among which include doubling or tripling of the intima-
media thickness, hypertrophy of the vascular smooth muscle layer, derangements in 
extracellular matrix, and excessive collagen production (Glagov et al., 1992; Nagai et al., 
1998; O’Leary et al., 1999; Salonen & Salonen, 1991; Virmani et al., 1991; Xu et al., 
2000). Indeed, the elastic modulus of excised arterial segments increased non-linearly 
with increasing pressure, and that, at any given pressure (Fig. 2), the modulus was higher 
in peripheral than central arterial segments (Bergel, 1961). 
 Interestingly, central pressure waves have been shown to be only augmented in 
young adults with high arterial pressure, further increasing after the 50 years of age and 
becoming markedly augmented in subjects with isolated systolic hypertension (Benetos et 
al., 2002; Nichols et al., 1993; Nichols & O’Rourke, 1998). 
 
Other Associated Risk Factors 
Other risk factors have less confidently been associated with arterial stiffening. 
While these risk factors may not be the direct cause of arterial stiffening, the addition of 
such risk factors on top of an already stiffening artery likely exacerbates stiffening. 
Among the other cardiovascular risk factors, the presence of dyslipidemia (Lehmann et 
al., 1995), diabetes (Emoto et al., 1998), high heart rate (Sa Cunha et al., 1997), and 
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tobacco smoking (Stefanadis et al., 1997) are often associated with increased stiffness, 
but the impact of these risk factors in the development of arterial stiffness remains 
unclear. A few of the commonly described risk factors that may influence stiffening are 
gender, heart rate, cigarette smoking, diabetes mellitus. 
Gender. Change in aortic elasticity is similar in both males and females for the 
first 10 years of life (Laogun & Gosling, 1982). Thereafter, greater declines in aortic 
distensibility and stiffness (Laogun & Gosling, 1982; Sonesson et al., 1993) have been 
reported in males compared to females. By approximately 60 years of age, both sexes are 
comparable with menopause and loss of estrogen being the contributing factor for 
evening out measures of aortic elasticity (Rajkumar et al., 1997). 
Heart rate. Using atrial pacing, it has been shown that heart rate changes were 
able to influence arterial distensibility (Mangoni, et al., 1996). Because the viscous 
component of the elastic wall is highly frequency dependent, it can be expected that 
higher heart rate values are associated with reduced distensibility. The shortening of the 
time available for recoil may be a plausible, although not an exclusive, explanation for 
decreased distensibility; however, a shortened recoil period may lend itself to increases in 
pulse wave propagation speed. Conversely, decreased augmentation is observed with 
increased heart rate likely due to a decreased ventricular ejection period resulting in late 
diastole augmentation versus systole (O’Rourke et al., 2001; Wilkinson et al., 2000). 
Indeed, chronic increases in heart rate contribute to arterial fatigue and to atherosclerotic 
lesions (Bassiouny et al., 1994) and are a significant determinant of arterial stiffness in 
hypertensives (Albaladejo et al., 2000; Sa Cunha et al., 1997). 
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Cigarette smoking. Smoking is associated with acute decreases in arterial 
distensibility in both normotensive and hypertensive individuals, and is independent of 
increases in blood pressure (Failla et al., 1997; Giannattasio et al., 1994; Kool et al., 
1993). Furthermore, women tend to be more vulnerable to the vascular decrements from 
smoking than men, despite the higher aortic elasticity in women prior to menopause 
(Sonesson et al., 1997). 
 Diabetes Mellitus. Previous studies have shown that aortic PWV is greater in 
subjects with diabetes than in controls (Cruickshank et al., 2002; Dabelea et al., 2013). 
While acute hyperglycemia in non-diabetic individuals likely does not influence carotid 
artery elasticity (Lambert et al., 1997), chronic hyperglycemia in diabetics is associated 
with reduced aortic elasticity independent of atherosclerosis or other clinical 
complications of diabetes (Oxlund et al., 1989). Indicators of glucose intolerance have 
been related to arterial stiffness (Amar et al., 2001; Emoto et al., 1998; Lehmann et al., 
1992). Among type I diabetic subjects, arterial stiffening may be found in the absence of 
any diabetic-related complication, suggesting that in diabetes stiffening may be an early 
marker of vascular damage (Lacolley et al., 2001). The association may be due to high 
levels of insulin, or directly, by having elevated glucose levels leading to collagen cross 
linkage due to non-enzymatic glycation and its end-products deposited in the arterial wall 
(Airaksinen et al., 1993; Sims et al., 1996). Arterial stiffness has also been reported in 
pre-diabetic states (Salomaa et al., 1995). A 25% increase in fasting glucose is 
associated with increased artery stiffness. Nonetheless, determination of aortic 
stiffness or measurement of pulse wave contour have not been shown to aid in the 
   33 
diagnosis of diabetes mellitus, nor definitely proven to assist in assessment of its severity 
(O’Rourke et al., 2001). 
 
Cardiovascular Outcomes Associated with Arterial Elasticity and Stiffness  
 Stiffening of the larger central arterial system significantly contributes to CVD 
outcomes in older individuals and is positively associated with systolic hypertension 
(Franklin et al., 1997), end-stage renal disease mortality (Blacher et al., 1998), chronic 
kidney disease (Blacher et al., 2003; London et al., 1998; London et al., 2001), coronary 
artery disease and mortality (Benetos et al., 1998; Sutton-Tyrrell et al., 2005), stroke 
(Sutton-Tyrrell et al., 2005), heart failure (Chae et al., 1999), and atrial fibrillation 
(Mitchell et al., 2007). Indeed, the elastic properties of the aorta are related to the degree 
of coronary artery disease (Hirai et al., 1989; Stefanadis et al., 1990). Stroke patients also 
have less abdominal aorta distensibility (Lehmann et al., 1995). Additionally, 
hemodialysis patients have reduced aortic and carotid compliance despite compensatory 
aortic dilatation (London et al., 1990). Indeed, dialysis is strongly associated with 
reduced carotid compliance in renal transplant patients (Barenbrock et al., 1993). 
Furthermore, arterial stiffness is said to synergistically increase in proportion to the 
number of cardiovascular risk factors and clinical events (Lehmann et al., 1998).  
 
Summary 
 While there appears to be a reliable relationship between risk factors such as 
advanced aging and hypertension with decreased arterial elasticity and increased 
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stiffness, studies of carotid arterial elasticity in otherwise healthy populations are lacking. 
Specifically in young adolescents, carotid artery elasticity differences throughout pubertal 
development have never been adequately evaluated. Additionally, sex differences in 
otherwise healthy individuals have not been extensively evaluated. Possible decrements 
in vascular mechanics in an otherwise healthy and young population may support usage 
of therapeutic remedies to offset further vascular dysfunction. Indeed, the following 
dissertation further evaluates whether a therapeutic dose of atorvastatin modulates 
vascular dysfunction in childhood cancer survivors, a population known to have an 
increased risk of cardiovascular disease. 
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SUMMARY 
 
Background: Cardiovascular and metabolic risk factor levels differ by pubertal stage. 
However, little is known about the relation of pubertal development on endothelial 
function and arterial elasticity in children and adolescents. Objective: We compared 
brachial artery flow-mediated dilation (FMD) and carotid artery elasticity across Tanner 
(pubertal) stages in children and adolescents. Methods: Blood pressure, fasting lipids, 
glucose, and insulin, body fat, insulin sensitivity (Mlbm), brachial FMD (percent dilation 
and area-under-the-curve), endothelium-independent dilation (EID peak dilation and 
area-under-the-curve), and carotid artery elasticity were evaluated across pubertal stages 
(Tanner I vs. Tanner II-IV vs. Tanner V) in 344 children and adolescents (184 males, 160 
females; ages 6 to 21 years). Results: 124 subjects (mean age 8.23±0.15 years; 52 
females) were Tanner stage I; 105 subjects (mean age 13.19±0.17 years; 47 females) 
were Tanner stages II-IV; and 115 subjects (mean age 17.19±0.16 years; 61 females) 
were Tanner stage V. There were no significant differences for any of the measures of 
vascular structure and function across pubertal stages. Conclusion: Results of the current 
study indicate smooth muscle and endothelial function, as well as carotid artery elasticity, 
do not differ throughout pubertal development and that accounting for pubertal stage 
when reporting vascular data in children and adolescents may be unnecessary.  
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INTRODUCTION 
Throughout puberty, transient changes in cardiometabolic risk factors occur as a 
normal part of development. The relationship between puberty and cardiometabolic 
factors, such as body fatness, body mass index (BMI), lipids, and insulin resistance has 
been well documented (Amiel et al., 1986; Bloch & Clemons, 1987; Caprio et al., 1989; 
Caprio et al., 1994; Caprio & Tamborlane, 1994; Cook et al., 2003; Goran & Gower, 
2001; Gower, 1999; Moran et al., 1999; Richards et al., 1992; Sinaiko et al., 2001; 
Travers et al., 1995; Uwaifo et al., 2002). Specifically, increased insulin resistance is 
often associated with pubertal onset, with levels returning to near pre-pubertal status 
following maturation (Moran et al., 1999). Although insulin resistance is associated with 
adiposity throughout childhood and adolescence (Moran et al., 1999; Richards et al., 
1992; Sinaiko et al., 2001), differences in body fatness do not entirely explain the 
development of insulin resistance during puberty (Goran & Gower, 2001; Moran et al., 
1999; Sinaiko et al., 2001). Although not firmly established, it is possible that insulin 
resistance influences vascular health during pubertal development in children and 
adolescents. 
A number of studies among children and adolescents have also reported that 
endothelial function, as measured by flow-mediated dilation (FMD), is associated with 
obesity (Tounian et al., 2001), dyslipidemia (Järvisalo, Lehtimäki, & Raitakari, 2004), 
blood pressure (Farpour-Lambert et al., 2009), insulin resistance (Tounian et al., 2001; 
Kapiotis et al., 2006), and oxidative stress (Järvisalo, Lehtimäki, & Raitakari, 2004). 
Limited studies have measured arterial elasticity among children and adolescents 
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(Chalmers et al., 2011; Reed et al., 2005). Among adults, BMI and elements of metabolic 
syndrome have been reported to have an inverse relationship with large and small artery 
compliance (Acree, Montgomery, & Gardner, 2007; Fjeldstad et al., 2007). Although it 
has been well-documented that cardiovascular and metabolic risk factors differ by 
pubertal stage, to our knowledge, no studies have examined whether measures of vascular 
function and stiffness differ among pubertal stages among children and adolescents. 
Therefore, the purpose of this study was to evaluate the influence of Tanner stage on 
endothelial function and arterial elasticity among children and adolescents. We 
hypothesized that vascular variables would differ by pubertal stage in accordance with 
associated changes in cardiometabolic risk factors. Specifically, we hypothesized that 
FMD and arterial elasticity would be lowest among Tanner stages II-IV compared to 
Tanner stages I and V. 
 
MATERIALS AND METHODS 
The study protocol was approved by the University of Minnesota Institutional 
Review Board (IRB). The study procedures adhered to the University of Minnesota’s 
IRB and the Health Insurance Portability and Accountability Act (HIPAA) guidelines. 
All parents and subjects provided informed consent and assent, respectively, for study 
participation. 
 
Study Population 
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Three hundred and forty-four subjects (184 males, 160 females), who had 
participated in a study evaluating cardiovascular risk among families, were included in 
this cross-sectional study. Enrolled children and adolescents were between the ages of 6 
and 21 years of age (mean age 12.7±4.1 years). Subjects had been fasting for at least 
eight hours prior to the vascular assessment and were asked to abstain from caffeine 
ingestion on the morning of testing and to avoid strenuous exercise or physical activity 
for 24 hours prior to the study visit. Subjects who were greater than 18 years of age were 
excluded from BMI-percentile, SBP-percentile, and DBP-percentile calculations. 
 
Measurements 
 
Physical Assessments 
Measurements for height and weight were obtained with a standard stadiometer 
(Ayrton, Model S100, Prior Lake, MN, USA) and electronic scale (ST Scale-Tronix, 
Serial No. 5002-8893, White Plains, NY, USA), respectively. Body mass index (BMI) 
was calculated as weight in kilograms divided by height in meters-squared. Body 
composition was obtained using dual energy X-ray absorptiometry (DXA) (Lunar 
Prodigy, Software version 10.5, GE Healthcare Lunar, Madison, WI, USA). Blood 
pressure percentile data was classified based on The National Heart, Lung, and Blood 
Institute (NHLBI) guidelines. 
 
Clinical Assessments 
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Seated blood pressure was measured by a random-zero sphygmomanometer on 
the right arm, and the average of two systolic blood pressure (SBP) measurements and 
fifth phase Korotkoff diastolic blood pressure (DBP) measurements were analyzed. 
Tanner staging of pubertal development was performed by trained providers and was 
based on breast and pubic hair development in girls and pubic hair development in boys. 
Participants were classified as pre-pubertal (Tanner I), pubertal (Tanner II-IV) and post-
pubertal (Tanner V). 
Insulin sensitivity, adjusted for lean body mass (Mlbm), was determined by 
euglycemic hyperinsulinemic clamp as previously described (Sinaiko et al., 2001). 
Fasting blood samples were obtained for serum insulin and lipids, as well as plasma 
glucose. Insulin levels were determined using a chemoluminescence immunoassay 
(Immulite Insulin DPC, Los Angeles, CA). Samples for serum lipids were analyzed with 
standard procedures at the Fairview-University Medical Center clinical laboratory.  
 
Vascular Assessments 
Testing was performed in the Vascular Biology Laboratory in the University of 
Minnesota Clinical and Translational Science Institute. All the vascular studies were 
performed in a quiet, temperature-controlled environment (22-23°C). Vascular images 
were measured by a non-invasive ultrasound with subjects in the supine position. Images 
were digitized and stored on a personal computer for later off-line analysis with an 
electronic wall-tracking software program (Vascular Research Tools 5, Medical Imaging 
Application, LLC, Iowa City, IA, USA).  
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FMD and EID. Following 15 minutes of quiet rest in the supine position, vascular 
images of the brachial artery were obtained using a conventional ultrasound scanner 
(Acuson, Sequoia 512, Siemens Medical Solutions USA, Inc., Mountain View, CA, 
USA) with a 7.5 MHz linear array probe held at a constant distance from the skin and at a 
fixed point over the imaged artery. Assessment of FMD was performed by imaging the 
left brachial artery at the distal third of the upper arm using techniques previously 
described (Celermajer et al., 1992; Kelly et al., 2004). After a 15-minute break following 
FMD assessment, endothelium-independent dilation (EID) was assessed using 0.3 mg 
sublingual nitroglycerin (NTG), the dose considered appropriate by the University of 
Minnesota Institutional Review Board for subjects <18 years old, and 0.4 mg sublingual 
NTG for subjects 18+ years old. Brachial artery diameter was assessed continuously for 5 
minutes post-NTG administration. Peak dilation during the study was defined as the 
greatest percent change from resting brachial artery diameter, while area under the curve 
(AUC) was defined as the total relaxation of the brachial artery from resting baseline 
following reactive hyperemia or sublingual nitroglycerin administration.  
Carotid arterial elasticity. Carotid artery images, as well as supine systolic and 
diastolic blood pressure and pulse pressure, were concurrently measured by a non-
invasive ultrasound with subjects in the supine position. Following 15-min of quiet rest in 
the supine position, luminal systolic and diastolic diameters were obtained at a fixed 
point over the left common carotid artery, approximately 1 centimeter proximal from the 
carotid bulb. Images were collected at 20 frames per second for 10 seconds (200 frames) 
to ensure the capture of full arterial diameter change during a cardiac cycle. Systolic and 
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diastolic blood pressures were recorded with an automated blood pressure 
sphygmomanometer during the 10-second carotid measurement. The mean diameter 
through the 10-second cycle was used to calculate measures of compliance and 
distensibility. The ultrasound scanning system was interfaced with a standard personal 
computer equipped with a data acquisition card for attainment of radio frequency 
ultrasound signals from the scanner. Digital image analysis was performed by the same 
trained reader blinded to group assignments. 
Pulse pressure (∆P) was calculated as the difference between systolic and 
diastolic pressures. Additionally, maxDiamM denotes maximum diameter measurement, 
and minDiamM denotes minimum diameter measurement. 
 
Statistical Analysis 
SAS Software Package (Version 9.2, 2009, SAS Inc., Cary, NC, USA) was used 
for statistical analyses. Our study data was segmented into Tanner stages I, II-IV, and V 
groupings due to the equal-size, homogenous clusters within each stage of our study 
population. Results are expressed as mean±standard deviation (SD), unless otherwise 
stated. A one-way analysis of variance (ANOVA) was used to compare demographic 
characteristics by pubertal stage groups, as well as to compare vascular measures 
between-groups of pubertal stage groups, adjusting for age, sex, race, and baseline 
brachial artery diameter. An alpha value of 0.05 was used to signify statistical 
significance. 
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RESULTS 
Tanner stage I included 124 children (mean age 8.23±0.15 years; 52 females); 
Tanner stages II-IV included 105 children and adolescents (mean age 13.19±0.17 years; 
47 females); and Tanner stage V included 115 adolescents (mean age 17.19±0.16 years; 
61 females).  
Table 1 shows the descriptive and clinical characteristics of the three pubertal 
groups. Percent body fat and systolic blood pressure were significantly (P<0.001) lower 
among Tanner stage I, while diastolic blood pressure was significantly (P<0.002) higher 
among Tanner stage V. SBP-percentile (P=0.48) was not significantly different among 
pubertal groups. DBP-percentile was significantly (P=0.003) lower in Tanner I than in 
Tanner II-IV; however, no significant difference was observed between Tanner II-IV and 
Tanner V. Fasting glucose and insulin were significantly different among the pubertal 
groups, with Tanner stage I having significantly (P<0.0001) lower fasting glucose and 
insulin levels than both Tanner stages II-IV and Tanner stage V. Tanner stages II-IV and 
Tanner stage V trended towards being significantly (P=0.095) different, with Tanner 
stages II-IV reporting higher values. Mlbm was significantly different between all 
pubertal stage groups, with Tanner stage I exhibiting the highest values, followed by 
Tanner stages II-IV, then Tanner stage V (all P<0.05). Total cholesterol and LDL-
cholesterol were significantly (P<0.05) higher among Tanner stage I, while HDL-
cholesterol was significantly (P<0.005) lower among Tanner stage V. Furthermore, 
triglycerides increased with pubertal progression, with Tanner stage V observed to be 
significantly (P<0.0003) larger than Tanner stage I. Overall, mean descriptive and 
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clinical measurements were observed to be within normal reference ranges for children 
and adolescents. 
Table 2 shows the vascular response measures of the three pubertal groups. 
Baseline brachial artery diameter significantly increased (P=0.012) with pubertal 
progression. Specifically, significant differences between Tanner I and Tanner II-IV 
(P=0.014), as well as Tanner II-IV and Tanner V (P=0.028) were observed. Vascular 
measures, following adjustments by age, sex, race, and resting diameter, revealed no 
significant differences by pubertal stage groups for FMD (P=0.68), FMD-AUC (P=0.91), 
EID (P=0.88), EID-AUC (P=0.92), diameter distensibility (DD) (P=0.66), cross-
sectional distensibility (CSD) (P=0.66), diameter compliance (DC) (P=0.18), or cross-
sectional compliance (CSC) (P=0.41); these findings did not change with additional 
adjustment for BMI-percentile. A separate analysis was also performed with adjustments 
for age, sex, and race (excluding resting diameter), and overall conclusions were the 
same; moreover, FMD (P=0.33), FMD-AUC (P=0.68), EID (P=0.46), EID-AUC 
(P=0.17), DD (P=0.86), CSD (P=0.86), DC (P=0.29), and CSC (P=0.36) were not 
significantly different by pubertal stage groups.  
A gender-stratified analysis was also performed with adjustments for age, race, 
baseline diameter, and both with and without adjustment for BMI-percentile, revealing no 
significant difference between the Tanner stage groups for male and female children and 
adolescents separately. 
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DISCUSSION 
The findings of the current study indicate that adjusting for pubertal stage might 
not be necessary when reporting vascular data among children and adolescents. The 
vascular findings are consistent with previously reported studies (Celermajer et al., 1994; 
van der Heijden-Spek et al., 2000), which have suggested that resting brachial artery 
diameter was higher in each respective pubertal stage group. However, this appeared to 
have no impact on endothelial function across groups. In contrast to our findings, 
however, Bhangoo et al. (2011) reported that endothelial peripheral arterial tonometry 
(EndoPAT) index, a measure of small artery endothelial function, increased with pubertal 
progression (Tanner stage I to Tanner stages IV-V) and was significantly correlated with 
age in healthy children and adolescents. The divergent findings may be explained by the 
inherent differences in the vascular beds evaluated (conduit versus small artery). Arterial 
dilation in the conduit arteries is mostly dependent on nitric oxide whereas multiple 
factors contribute to dilation in the small arteries. In addition, smooth muscle is much 
more abundant in the conduit arteries. Finally, it is also possible that the “one size fits all” 
finger probes used with the EndoPAT device assessment provide less accurate reactive 
hyperemic index values in younger children. Future research should investigate the 
differences in conduit versus small artery endothelial function across pubertal stages in 
healthy children and adolescents, as well as diseased populations. 
A notable observation of the current study was the lack of difference in smooth 
muscle function (EID) throughout pubertal development. This finding is important since 
the use of NTG in children is controversial and the lack of difference in EID across the 
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pubertal groups in this study suggests that evaluation of smooth muscle function in 
children may be unnecessary. Additionally, future studies looking at smooth muscle 
function in children may not need to account for pubertal development.  
Although not statistically significant, the current study showed higher carotid 
artery compliance and endothelial function, specifically FMD and FMD-AUC, among the 
Tanner stage I group. It is unclear whether these differences are clinically meaningful; 
however, this should be considered in studies where pre-pubertal children are compared 
to pubertal children. 
The Tanner staging method used within the present study has been the standard 
for assessing the degree of pubertal development for more than 30 years (Marshall & 
Tanner, 1969; Marshall & Tanner, 1970), and it is the method used in previous studies of 
insulin resistance during puberty (Amiel et al., 1986; Travers et al., 1995; Cook et al., 
1993; Amiel et al., 1992). Inherent in this method is a discordance between pubic hair 
growth and breast development in girls (Marshall & Tanner, 1969). We scored both pubic 
hair and breast development in girls and used the greater of the two values for statistical 
analysis so that pubertal maturation would not be underestimated. While pubic hair 
staging in boys often corresponds with testicular volume, pubic hair staging is not always 
the most accurate measure of gonadal maturation. Nonetheless, exclusion of genital 
examination was found to improve patient compliance with the study protocol. 
Strengths of the current study include a relatively large sample size, balanced 
Tanner stage groups and the use of the euglycemic, hyperinsulinemic clamp, the gold 
standard technique for measuring insulin sensitivity. The primary limitation of the study 
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was its cross-sectional nature. A longitudinal design would be preferred in order to better 
address the temporal association of pubertal development and arterial health. 
In summary, the results from this cross-sectional study indicate that neither 
vascular function nor arterial compliance differs across pubertal stages in children and 
adolescents even though cardiometabolic risk factor levels vary. While it is important to 
report Tanner stage in studies involving children and adolescents, the current findings 
suggest that adjustments for pubertal stage might not be necessary when reporting 
vascular data among children and adolescents. Future prospective longitudinal studies 
should assess whether transient changes in cardiometabolic risk factor levels during 
puberty influence vascular health to confirm the results of the current study. 
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TABLE LEGENDS 
Table 1. Mean (±SD) Demographic and Clinical Characteristics 
Table 2. LSmeans(SE) Vascular Response Measures 
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Table 1. Mean(SD) Demographic and Clinical Characteristics 
 Tanner I 
(n=124) 
Tanner II-IV 
(n=105) 
Tanner V 
(n=115) 
Overall 
P-value 
Age (yrs) 8.23(0.15) 13.19(0.17) a 17.19(0.16) b,c <0.0001 
Male, n(%) 58.1(4.5) 55.2(4.9) 46.9(4.7) 0.21 
Race, n(%)     
  White 77.4(3.9) 81.9(4.3) 48.7(4.1) b,c <0.0001 
  Black 16.9(3.6) 11.4(3.9) 35.7(3.7) b,c <0.0001 
Height (cm) 133.4(0.88) 159.8(0.96) a 169.7(0.92) b,c <0.0001 
Weight (kg) 31.3(1.4) 54.9(1.5) a 73.6(1.4) b,c <0.0001 
BMI-Percentile † 59.3(2.5) 65.7(2.7) 70.3(2.6) b 0.011 
Percent Body Fat, 
DXA, % 
20.9(1.0) 26.0(1.0) a 28.2(1.0) b <0.0001 
SBP, mmHg 100.2(0.89) 108.0(0.97) a 110.5(0.92) b <0.0001 
SBP-percentile § 47.4(2.4) 47.7(2.5) 43.3(3.1) 0.48 
DBP, mmHg 56.9(0.69) 57.4(0.75) 60.7(0.72) b,c 0.0002 
DBP-percentile § 40.3(1.9) 32.1(2.0) a 29.8(2.5) b 0.0008 
Fasting Glucose 
(mg/dL) 
70.1(1.1) 86.7(1.1) a 84.9(1.0) b <0.0001 
Fasting Insulin (mU/L) 4.0(0.62) 11.2(0.62) a 9.78(0.59) b <0.0001 
Mlbm (mg/kg lbm/min) 15.8(0.74) 13.1(0.39) a 11.8(0.38) b,c <0.0001 
Total Cholesterol 
(mg/dL) 
156.0(2.6) 145.9(2.6) a 147.3(2.5) b 0.011 
LDL-Cholesterol 
(mg/dL) 
91.0(2.1) 81.6(2.1) a 84.6(2.1) b 0.007 
HDL-Cholesterol 
(mg/dL) 
52.3(1.1) 50.7(1.1) 46.4(1.0) b,c 0.0003 
Triglycerides (mg/dL) 63.3(3.9) 73.4(3.9) 83.5(3.8) b 0.0014 
Standard Error of the Mean (SEM) used, unless otherwise noted. P-values <0.05 demonstrate 
significant differences between Tanner stages I, II-IV, and V. BMI, body mass index; SBP, 
systolic blood pressure; DBP, diastolic blood pressure; Mlbm, insulin resistance (mg per 
kilogram of lean body mass); LDL, low-density lipoproteins; HDL, high-density lipoproteins. 
†Denotes Tanner group size (n=124, 105, 110). §Denotes Tanner group size (n=123, 105, 72). 
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Table 2. LSmeans(SE) Vascular Response Measures 
 Tanner I 
(n=124) 
Tanner II-IV 
(n=105) 
Tanner V 
(n=115) 
Overall 
P-value 
Baseline Diameter 
(mm) 
2.96(0.07) 3.17(0.04) a 3.34(0.07) b,c 0.012 
FMD (%) 8.6(0.59) 7.96(0.37) 7.88(0.58) 0.68 
FMD-AUC, %-s-1 805.4(74.5) 772.9(46.5) 786.1(73.5) 0.91 
EID (%) 23.7(1.40) 24.4(0.67) 24.5(0.77) 0.88 
EID-AUC, %-s-1 3870.3(264.8) 3768.7(126.1) 3758.0(141.1) 0.92 
DD (%) 14.5(0.59) 15.1(0.37) 15.4(0.58) 0.66 
CSD (%) 31.2(1.4) 32.7(0.9) 33.2(1.3) 0.66 
DC, mm-mmHg-1 0.013(0.002) 0.018(0.001) 0.018(0.002) 0.18 
CSC, mm2-mmHg-1 0.18(0.008) 0.16(0.005) 0.16(0.008) 0.41 
LSmeans(SE) adjusted for Age, Sex, Race, and Baseline Diameter. P-values <0.05 
demonstrate significant differences among Tanner stages I, II-IV, and V. Baseline diameter 
(baseline brachial artery diameter at rest); FMD, flow-mediated dilation; FMD-AUC, 
flow-mediated dilation area-under-the-curve; EID, endothelium-independent dilation; EID-
AUC, endothelium-independent dilation area-under-the-curve; DD, diameter distensibility; 
CSD, cross-sectional distensibility; DC, diameter compliance; CSC, cross-sectional 
compliance. 
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SUMMARY 
Background: Given its association with the development of cardiovascular disease, 
compliance and distensibility measures of carotid arterial elasticity have been commonly 
used over the last decade as predictors of cardiovascular risk. However, the gender 
differences for these measures are unknown. Objective: The purpose of this study was to 
evaluate the impact of gender on carotid arterial elasticity in a large sample of children 
and adults. Methods: Arterial elasticity measures of the carotid artery were obtained with 
ultrasound imaging in 294 children (157 males, 137 females; 6 to 18-yrs) and 604 adults 
(291 males, 311 females; 18-49 yrs) previously recruited for a study investigating 
cardiovascular risk factors. An independent sample t-test was used to compare 
demographic and carotid artery elasticity measures by age and gender. Results: No 
significant gender differences in carotid arterial compliance and distensibility were 
observed in children. Adult females had significantly greater cross-sectional compliance 
compared to adult males (0.004±0.000 vs. 0.003±0.000 mm2/mmHg, P=0.041). 
Conclusions: A significant gender difference in carotid compliance was present in adults, 
but not in children. Thus, data from this study suggests that gender differences in arterial 
stiffness are not present early in life, but emerge later in adulthood.  
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INTRODUCTION 
Arterial elasticity has become an increasing focal point in the past decade because 
of its association with cardiovascular disease (CVD) (Fjeldstad, Montgomery, & 
Gardner, 2008; Havlik et al., 2003). The two most common measures of arterial elasticity 
are compliance and distensibility. By definition, compliance is the unit change in volume 
induced by a unit change in pressure, or the absolute change in arterial volume that 
reflects the arterial ability to store volume and reduce pressures (Jani & Rajkumar, 2006; 
Reneman, Meinders, & Hoeks, 2005), and distensibility is the relative change in arterial 
volume against the change in pressure and reflects the mechanical load placed on the 
arterial wall (Reneman, Meinders, & Hoeks, 2005).  
Lower arterial compliance (i.e., the ability to expand and recoil), and/or increased 
arterial stiffness, is common with advancing age in both men and women (Arnett, Evans, 
& Riley, 1994; Mitchell et al., 2004). Increased arterial stiffness is also associated with 
CVD risk factors, such as hypertension, hypertriglyceremia, type 2 diabetes mellitus, and 
aging (Fjeldstad, Montgomery, & Gardner, 2008; Jani & Rajkumar, 2006; Avolio et al., 
1985; Liao et al., 1999; Olinic et al., 2003; Prisant, Resnick, & Hollenberg, 2001; Snijder 
et al., 2004; van Popele et al., 2001). Moreover, arterial stiffening impairs the ability of 
the arterial system to handle the spontaneous elevation in blood pressure at systole, which 
leads to increases in systolic blood pressure and left ventricular mass, as well as 
decreases in diastolic blood pressure and diastolic coronary perfusion (Westerhof & 
O’Rourke, 1995).  
Assessment of arterial compliance and distensibility within larger conduit arteries, 
such as the carotid artery, is a widely-used technique to examine vascular elasticity and 
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arterial stiffness (Avolio et al., 1983; Benetos et al., 1993; Boutouyrie et al., 1992; 
Kawasaki et al., 1987; Länne et al., 1992; Laogun & Gosling, 1982; Reneman et al., 
1986; Sonesson et al., 1993; Tseke et al., 2006) given the abundance of elastic and 
collagen fibers within these arteries compared to smooth muscle fibers largely abundant 
in the peripheral vasculature. One may suspect there would exist a relationship between 
brachial and carotid arterial compliance and distensibility if arterial stiffness was 
systemically induced rather than occurring regionally.  
The primary objective of this study was to evaluate the differences related to 
gender in carotid arterial elasticity measures in children and adults. We also examined, in 
a subset of participants, whether a relationship exists between brachial and carotid arterial 
elasticity measures. Gender differences relative to arterial stiffness, as well as potential 
arterial stiffness associations among different vascular beds, is critical to 
comprehensively understand the progression of atherosclerotic diseases and may 
showcase arterial differences with aging. We hypothesized that carotid artery elasticity 
will differ by gender and that differences will become more apparent with age (i.e., better 
identifiable in the adults compared to children). Additionally, we hypothesized that an 
association between brachial and carotid arterial elasticity may exist. 
 
MATERIALS AND METHODS 
The study protocol was approved by the University of Minnesota Institutional 
Review Board (IRB). The study procedures adhered to the University of Minnesota’s 
IRB and the Health Insurance Portability and Accountability Act (HIPAA) guidelines. 
All subjects submitted written informed consent and assent for study participation. 
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Study Population 
Eight hundred and ninety-eight subjects (448 males, 450 females) between the 
ages of 6 and 49-yrs (mean age 28.6±0.5 yrs; males: 28.1±0.7 yrs, females: 29.5±0.6 yrs) 
were included in the study. Subjects were recruited from a community-based sample and 
all subjects were healthy. These individuals were participants in a study investigating the 
early development of obesity, insulin resistance, and their interaction with associated 
cardiovascular risk factors. Subjects were stratified into 6 to 18-yrs and 18-49 yrs age 
group to separate the children from adults. Prior to vascular testing, subjects were asked 
to fast for 12-h and abstain from caffeine ingestion. Subjects were instructed to withhold 
morning medications until after vascular ultrasound testing, and refrain from strenuous 
physical activity 12-h prior to testing. A study physician and/or certified nurse 
practitioner was present to review study procedures and evaluation plans, prescription 
medications, and conduct comprehensive medical examinations including current and 
past medical history, review of systems (with particular attention to cardiovascular and 
endocrine issues), family history (with particular attention to cardiovascular disease and 
diabetes), and a physical examination. 
All 898 subjects had carotid compliance and distensibility measures and a smaller 
subset of 93 individuals (55 males, 38 females) also had brachial artery measures.  Data 
from this subset were further analyzed to determine if there is an association between 
brachial and carotid artery compliance and distensibility measures.  
 
Measurements 
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Testing was performed in the Vascular Biology Laboratory in the University of 
Minnesota Clinical and Translational Science Institute. All the vascular studies were 
performed in a quiet, temperature-controlled environment (22-23°C). 
 
Anthropometric and Blood Pressure Assessments 
Measurements for height and weight were taken at the start of the visit using a 
digital stadiometer. Body Mass Index (BMI) was calculated as weight in kilograms (kg) 
divided by height in meters-squared (m2). Seated blood pressure was obtained on the 
control arm using an automatic blood pressure monitor (Model BP-8800C; Colin Press-
Mate, San Antonio, TX, USA). 
 
Vascular Assessments 
Brachial and carotid artery images, as well as supine systolic and diastolic blood 
pressure and pulse pressure, were concurrently measured by a non-invasive ultrasound 
with subjects in the supine position. Both brachial and carotid artery images were 
digitized and stored on a personal computer for later off-line analysis of arterial 
compliance and distensibility. Electronic wall-tracking software was used for the analysis 
(Vascular Research Tools 5, Medical Imaging Application, LLC, Iowa City, IA, USA).  
Carotid artery measurements. Following 15-min of quiet rest in the supine 
position, vascular images were obtained of the carotid artery using the conventional 
ultrasound scanner (Acuson, Sequoia 512, Siemens Medical Solutions USA, Inc., 
Mountain View, CA, USA) with a 7.5 MHz linear array probe held at a constant distance 
from the skin and at a fixed point over the imaged artery. The transducer was held at a 
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constant distance from the skin and at a fixed point over the common carotid artery, 
approximately 1-cm proximal from the carotid bifurcation bulb, to capture the left 
common carotid artery’s lumen diastolic and systolic diameters. Images were collected at 
20 frames per second for 10-s (200 frames) to ensure the capture of full arterial diameter 
change during a cardiac cycle. The mean diameter through the 10-s cycle was used to 
calculate measures of compliance and distensibility. 
Brachial artery measurements. Following 15-min of quiet rest in the supine 
position, vascular images of the brachial artery in a smaller subset of 93 individuals were 
obtained using a conventional ultrasound scanner as previously described for carotid 
measurements. The transducer probe was held at a constant distance from the skin and 
the brachial artery was scanned in a fixed, longitudinal section 5 to 15-cm above the 
elbow with the assistance of a stereotactic arm. Depth and gain settings were set to 
optimize images taken of the lumen/arterial wall interface. The following procedures 
ensured consistency throughout subject analysis. Systolic and diastolic blood pressures 
were recorded with an automated blood pressure sphygmomanometer during both the 10-
s carotid and brachial measurements. The ultrasound scanning system was interfaced with 
a standard personal computer equipped with a data acquisition card for attainment of 
radio frequency ultrasound signals from the scanner. Brachial artery image collection 
measurements were conducted similar to carotid artery measures. 
Measurement Characteristics. In order to measure the brachial and carotid 
elasticity properties, the following formulas for distensibility and compliance were used: 
 
• Diameter distensibility (DD, %) is defined as [(maxDiamM - minDiamM)/ 
minDiamM] x 100%. 
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• Cross-sectional distensibility (CSD, %) is defined as [(π*(maxDiamM/2)2 - 
π*(minDiamM/2)2)/π*(minDiamM/2)2] x 100%. 
• Diameter compliance (DC, mm/mmHg) is defined as [(maxDiamM - 
minDiamM)/∆P]. 
• Cross-sectional compliance 1 (CSC1, mm2/mmHg) is defined as 
[(π*(maxDiamM/2)2 - π*(minDiamM/2)2)/(∆P)]. 
• Incremental elastic modulus (IEM, mmHg) is defined as 
3{1+[π*(maxDiamM/2)2/ π*(minDiamM/2)2]}/CSC1. 
 
Pulse pressure (∆P) is calculated as the difference between systolic and diastolic 
pressures. Additionally, maxDiamM denotes maximum diameter measurement, and 
minDiamM denotes minimum diameter measurement. Furthermore, although multiple 
technicians were involved in the data collection, the software program utilized for 
vascular image assessment and interpretation was automated and operator-independent, 
minimizing any variability among technicians. 
 
Statistical Analysis 
Stata/SE 12.0 (StataCorp, College Station, TX, USA) was used for statistical 
analyses. Results are expressed as mean ± standard error of the mean (SEM). An 
independent sample t-test was used to compare demographic characteristics, as well as 
carotid artery compliance and distensibility measures by gender within the 6 to 18-yrs 
and 18-49 yrs age groups. A multiple linear regression model was additionally used to 
adjust for age, gender, and BMI or BMI Percentile where these risk factors were 
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significantly different between genders in both age groups. Brachial versus carotid 
arterial compliance and distensibility measures were compared by Pearson’s Correlation 
analysis within the smaller subset. An alpha value of 0.05 was used to signify statistical 
significance.  
 
RESULTS 
 
Carotid Artery Elasticity Assessment 
Mean demographic data among both the male and female study population, 
stratified into two age groups (6 to 18-yrs, and 18-49 yrs) are presented in Table 1. For 
subjects 6 to 18-yrs of age, males were significantly taller (P=0.043), and had 
significantly higher seated systolic blood pressure (P<0.0001) and pulse pressure 
(P<0.0001) than females. Age (P=0.823), weight (P=0.309), BMI (P=0.895), BMI 
Percentile (P=0.957), and seated diastolic blood pressure (P=0.286) were not 
significantly different between males and females. For subjects 18-49 yrs of age, a 
significant difference in height (P<0.0001), weight (P<0.0001), as well as seated systolic 
blood pressure (P<0.0001), diastolic blood pressure (P=0.0001), and pulse pressure 
(P<0.0001) were reported between genders, with males reporting significantly higher 
values. Age (P=0.559) and BMI (P=0.270) were not significantly different between 
males and females. 
Carotid artery measures of compliance and distensibility are displayed in Table 2. 
The letter ‘c’ is used to denote ‘carotid’ classifications when referencing all compliance 
and distensibility measures. Within the 6 to 18-yrs age group, females reported 
significantly greater supine diastolic blood pressure (P=0.033) compared to males, while 
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males reported significantly greater supine pulse pressure (P=0.012) than females. No 
significant gender differences were reported among supine systolic blood pressure, 
diameter distensibility (cDD), cross-sectional distensibility (cCSD), diameter compliance 
(cDC), cross-sectional compliance 1 (cCSC1), and incremental elastic modulus (cIEM) 
measurements in children. Within the 18-49 yrs age group, males reported significantly 
greater supine diastolic blood pressure (P=0.0002) and supine pulse pressure (P=0.0001) 
compared to females, while females reported significantly greater cCSC1 (P=0.041) 
compared to males. Following adjustment for supine pulse pressure, cCSC1 was no 
longer significantly different between males and females (P=0.072). No significant 
gender differences were reported for cDD, cCSD, cDC, or cIEM measurements within 
the 18-49 yrs age group. 
 Additionally, adjustments for age, gender, and BMI Percentile in children or BMI 
in adults showed age was a significant negative predictor for adult cDD, cCSD, cDC, and 
cCSC1, yet was a significant positive predictor of cIEM for both children and adult age 
groups (P<0.05). BMI Percentile was a significant positive predictor of childhood cDD 
and cCSD, while BMI was a significant negative predictor of adult cDD, cCSD, cDC, 
and cCSC1 and a significant positive predictor of adult cIEM. Gender was not a 
significant predictor of any of the evaluated arterial elasticity measures. 
 
Brachial and Carotid Artery Elasticity Assessment 
 A subset of 93 individuals was further analyzed to assess the relationship 
between brachial and carotid artery compliance and distensibility measures. Mean data 
for this subset are presented in Table 3. The letter ‘b’ is used to denote ‘brachial 
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classifications when referencing all compliance and distensibility measures. Among the 6 
to 18-yrs age group, 39 subjects were available for analysis (22 males, 17 females). 
Among the 18-49 yrs age group, 54 subjects were available for analysis (33 males, 21 
females). Age was not significantly different between males and females in the 6 to 18-
yrs age group (12.0±0.7 vs. 12.5±0.8 yrs, P=0.639). Additionally, no significant 
differences among carotid or brachial measures of compliance and distensibility were 
reported within the 6-18 yrs age group. Within the 18-49 yrs age group, age was not 
significantly different between males and females (34.3±1.3 vs. 32.3±2.0 yrs, P=0.359). 
Adult males did report significantly larger cDD (P=0.004), cCSD (P=0.004), cCSC1 
(P=0.026) compared to adult females, while adult females reported significantly higher 
cIEM (P=0.043) compared to adult males. There were no significant differences present 
among bDD, bCSD, cDC, bDC, bCSC1, and bIEM compliance and distensibility 
measures. 
Brachial and Carotid Artery Elasticity Relationship. A significant correlation 
between brachial and carotid measures of compliance and distensibility was observed for 
DD (r=0.334, P=0.038), CSD (r=0.337, P=0.036), DC (r=0.367, P=0.025), and CSC1 
(r=0.391, P=0.017) among the 6 to 18-yrs age group. No significant correlation between 
compliance and distensibility measures was observed for IEM (r=0.113, P=0.499). 
Among the 18-49 yrs subjects, a significant correlation between brachial and carotid 
measures of compliance and distensibility was observed for IEM (r=0.300, P=0.028). No 
significant correlation was observed between brachial and carotid measures of DD 
(r=0.191, P=0.166), CSD (r=0.190, P=0.168), DC (r=0.094, P=0.501), and CSC1 
(r=0.243, P=0.090). 
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DISCUSSION 
To our knowledge, this is the first study to evaluate the influence of gender on 
carotid arterial elasticity measures in a large sample of children and adults. Most arterial 
stiffness studies to date have been conducted in adult populations given arterial stiffness 
is common within the aging process of the arterial wall (Hickler, 1990; Hodes, Lakatta, & 
McNeil, 1995; O’Rourke, 1971). Furthermore, arterial stiffness is an important early 
marker of atherosclerotic disease identification. This is the first study, to our knowledge, 
to examine compliance and distensibility differences between genders in children.  
 The present study demonstrated that adult females had significantly greater carotid 
artery compliance compared to adult males, whereas in children compliance among males 
and females was not significantly different. Decreased arterial compliance has been 
shown to correlate with increased age (Avolio et al., 1985; Laogun & Gosling, 1982; 
Avolio et al., 1983; Benetos et al., 2001; deSimone et al., 1997; Franklin et al., 1999; 
Kelly et al., 1989), as well as gender and obesity (Liao et al., 1999; Johnson et al., 1986; 
Riley et al., 1986; Safar, 2001). Studies also have shown that sex hormones play an 
important role in vasomotion and vascular remodeling. Indeed, vascular function has 
been shown to change throughout the menstrual cycle (Williams et al., 2001). 
Specifically, early luteal (EL) has been reported to significantly reduce flow-mediated 
dilation relative to early follicular (EF), late follicular (LF), and late luteal (LL) cycle 
stages, while whole body arterial compliance (WBAC) has been shown to significantly 
increase during the LF than in the EF and EL phases. Conversely, pulse wave velocity 
(PWV), a measure of regional compliance, did not vary over the four phases of the 
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menstrual cycle (Williams et al., 2001). Moreover, estradiol has been shown to promote 
nitric oxide (NO)-mediated vasodilatation, reduce vascular oxidative stress, and retard 
atherosclerosis (Lieberman et al., 1996; Skafar et al., 1997). Sherwood et al. (2007) also 
reported that the effects of estrogen on receptors in vascular smooth muscle may be age-
related; showing greater sensitivity in young, mature subjects as opposed to 
postmenopausal women. Furthermore, arterial stiffness and pulse pressure measures are 
often mitigated by sex steroids both pre- and post-puberty (Rossi et al., 2011). Therefore, 
the higher compliance of adult females compared to adult males may be due to the 
protective effects of estrogen. 
The present study is also the first to examine the relationship between brachial 
and carotid arterial elasticity measures. A significant correlation between brachial and 
carotid measures of compliance and distensibility was observed for DD, CSD, DC, and 
CSC1 among the children. The adult group, on the other hand, displayed a significant 
correlation between brachial and carotid measures of IEM only. A clearer association 
between brachial and carotid measures of compliance and distensibility within the 
younger age group may also be specific to the effects of aging; further lending support to 
the negative relationship between aging and vessel compliance observed in the present 
study. Furthermore, it is possible that the high BMI values in adults, in relation to the 
children, may have explained some of the differences in arterial elasticity and vascular 
bed correlations. It is also possible that aging may play a roll in the mechanical changes 
in the vasculature.  
Study strengths included the large sample size and wide age-range of the 
participants. A limitation of the study is that data on sexual development was not 
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available in all children; therefore, a potential relation between pubertal development and 
differences in carotid artery compliance could not be assessed. Another limitation within 
this study is that physical activity level was not assessed. Studies suggest that increased 
physical activity improves arterial elasticity (Arnett, Evans, & Riley, 1994; Tanaka et al., 
2000); therefore, future studies assessing arterial elasticity in both children and adults 
should account for physical activity levels. Within the present study, participants were 
instructed to avoid strenuous exercise 24-h prior to vascular imaging to help minimize 
variability from such physical activity effects. And finally, vascular assessments were not 
timed around the menstrual cycle in females, which can be considered a limitation since 
cycle stage likely influences vascular function (Williams et al., 2001). 
In summary, in this study of subjects between the ages of 6 and 49-yrs, adult 
females had significantly greater carotid artery compliance than adult males. No 
significant gender difference was observed within children suggesting that gender 
differences in arterial stiffness are not present early in life. A significant positive 
association also existed between brachial and carotid measures of DD, CSD, DC, and 
CSC1 group in the children, while a significant positive association between brachial and 
carotid IEM existed within the adult group. These findings suggest that arterial 
compliance and distensibility are somewhat similar among vascular beds during 
childhood but that differences emerge in adulthood. The clinical implications are not 
entirely clear; however, it is reasonable to speculate that arterial stiffening may occur 
earlier in certain vascular beds compared to others. Future research directed toward 
understanding the age at which arterial stiffening begins will have clinical and 
epidemiologic implications for early CVD prevention.   
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TABLE LEGENDS 
Table 1. Mean (±SEM) Demographic Characteristics 
Table 2. Mean (±SEM) Carotid Artery Compliance and Distensibility 
Table 3. Subset of Mean (±SEM) Brachial and Carotid Artery Compliance  
and Distensibility 
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Table 1. Mean (±SEM) Demographic Characteristics 
 6 to 18-yrs 18-49 yrs 
Male 
(n=157) 
Female 
(n=137) 
Male  
(n=291) 
Female  
(n=313) 
Age (yrs)       10.9±0.3 11.0±0.3 37.4±0.4 37.1±0.3 
Height (cm) 149.8±1.6 145.3±1.5* 178.5±0.4 164.6±0.4* 
Weight (kg) 48.8±2.0 46.0±1.9 91.5±1.1 79.4±1.3* 
BMI (kg/m2) 20.5±0.5 20.6±0.5 28.6±0.3 29.3±0.5 
BMI Percentile (%) 65.7±2.4 65.5±2.4 -- -- 
Seated SBP (mmHg) 105.2±0.8 100.4±0.8* 119.1±0.7 109.9±0.8* 
Seated DBP (mmHg) 56.9±0.6 57.8±0.7 74.2±0.6 70.5±0.7* 
Seated PP (mmHg) 48.3±0.7 42.5±0.7* 44.9±0.4 39.4±0.4* 
BMI, body mass index; Seated SBP, seated systolic blood pressure; Seated DBP, seated diastolic 
blood pressure; Seated PP, seated pulse pressure; *P-values <0.05 demonstrate significant 
differences between genders of the same age group (6 to 18-yrs, 18-49 yrs). 
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Table 2. Mean (±SEM) Carotid Artery Compliance and Distensibility 
 6 to 18-yrs 18-49 yrs 
Male 
(n=157) 
Female 
(n=137) P-value 
Male 
(n=291) 
Female 
(n=313) P-value 
Supine SBP 109.7±1.0 108.9±1.1 0.598 126.6±0.8 121.9±1.0 0.0002 
Supine DBP 55.2±0.7 57.3±0.7* 0.033 72.9±0.6 69.5±0.6* 0.0001 
Supine PP 54.4±0.8 51.6±0.8* 0.012 53.7±0.5 52.4±0.6* 0.089 
cDD 15.2±0.3 14.9±0.3 0.536 8.3±0.2 8.4±0.1 0.542 
cCSD 32.9±0.7 32.3±0.8 0.536 17.3±0.3 17.5±0.3 0.533 
cDC  15.8±0.5 15.8±0.4 0.963 10.6±0.2 10.4±0.3 0.587 
cCSC1 6.1±0.2 6.2±0.2 0.940 3.2±0.1 3.6±0.2* 0.041 
cIEM 963.7±42.6 918.7±26.6 0.386 1795.7±34.3 1760.7±49.5 0.566 
Notation “c” denotes carotid artery measures; SBP, systolic blood pressure (mmHg); Supine 
DBP, supine diastolic blood pressure (mmHg); Supine PP, supine pulse pressure (mmHg); DD, 
diameter distensibility (%); CSD, cross-sectional distensibility (%); DC, diameter compliance 
(mm/mmHg x 10-3); CSC1, cross-sectional compliance 1 (mm2/mmHg); IEM, incremental elastic 
modulus (mmHg). *P-values <0.05 denote significant differences between genders of the same 
age group (6 to 18-yrs, 18-49 yrs). 
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Notation “b” denotes brachial artery measures and “c” denotes carotid artery measures; DD, 
diameter distensibility (%); CSD, cross-sectional distensibility (%); DC, diameter compliance, 
mm/mmHg x 10-3; CSC1, cross-sectional compliance 1, mm2/mmHg x 10-3; IEM, incremental 
elastic modulus, mmHg. *P-values <0.05 denote significant differences between brachial and 
carotid arterial measures of the same age group (6 to 18-yrs, 18-49 yrs). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Subset of Mean (±SEM) Brachial and Carotid Artery Compliance and Distensibility 
 6 to 18-yrs 18-49 yrs 
Male 
(n=22) 
Female 
(n=17) P-value 
Male  
(n=33) 
Female  
(n=21) P-value 
cDD 15.0±0.6 15.3±0.8 0.756 11.0±0.6 8.5±0.4* 0.004 
bDD 3.0±0.2 2.6±0.3 0.320 2.5±0.2 2.7±0.3 0.572 
cCSD 32.3±1.4 33.0±1.8 0.772 23.4±1.3 17.8±0.9* 0.004 
bCSD 6.1±0.4 5.4±0.6 0.323 5.1±0.4 5.5±0.6 0.562 
cDC 16.2±0.1 17.6±0.1 0.262 13.1±0.7 11.4±0.7 0.089 
bDC 2.2±0.3 2.7±0.1 0.628 1.8±0.1 2.3±0.4 0.104 
cCSC1 6.0±0.3 6.5±0.3 0.215 4.3±0.3 3.5±0.2* 0.026 
bCSC1 1.4±0.3 2.2±0.1 0.423 1.4±0.3 1.7±0.3 0.792 
cIEM 898.5±34.6 814.9±40.9 0.125 1324.4±77.1 1574.3±90.6* 0.043 
bIEM 5617.5±429.1 6170.9±866.2 0.544 6838.3±502.3 6091.5±515.9 0.326 
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SUMMARY 
Background: Many adult survivors of childhood cancer are at high risk of developing 
cardiovascular disease (CVD). Research suggests chemotherapy and radiation may cause 
damage to the vascular endothelium, thereby initiating atherosclerosis and progression to 
CVD. Atorvastatin has been shown to improve endothelial function independent of 
reducing cholesterol, as well as reduce arterial stiffness and slow arterial thickening in 
multiple populations, yet has never been studied in childhood cancer survivors (CCS). 
The objective of this pilot clinical trial was to evaluate the effects of atorvastatin on 
vascular health in young adult CCS. Methods: Twenty-seven young adult (mean age 
26.8±6.2 years; 14 male, 13 female) survivors of childhood acute lymphoblastic leukemia 
(ALL) or Non-Hodgkin’s lymphoma (NHL) were randomly assigned (1:1) to receive 40 
mg of atorvastatin once daily or placebo for 6 months. Participants had been treated for 
cancer before 21-yrs of age and were ≥5-yrs post-treatment. The primary endpoint was 
brachial artery flow-mediated dilation (FMD). Secondary endpoints included small artery 
reactive hyperemia index (RHI), arterial stiffness, and carotid artery elasticity and 
thickness. Results: Fifteen participants completed the trial and had vascular outcome 
measures available at follow-up. There was not a significant treatment effect on the 6-
month change from baseline for any primary or secondary vascular outcome measure. 
Specifically, treatment effect on peak FMD and RHI was 2.3 [95% CI: -0.4, 5.0] and 0.37 
[95% CI: -0.05, 0.80], respectively. No meaningful changes in arterial stiffness, carotid 
arterial elasticity or thickness were observed. Conclusion: Six months of atorvastatin 
treatment did not significantly improve endothelial function or arterial stiffness in young 
adult CCS. However, these findings should be interpreted with caution owing to the small 
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number of evaluable participants. Future trials will require much larger sample sizes to 
sufficiently study this question. This trial was registered at clinicaltrials.gov as 
NCT01733953. 
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INTRODUCTION 
The prevalence of childhood cancer survivorship has increased steadily over the 
past three decades (Ries et al., 1999). Progressively more effective surgical interventions, 
radiotherapy, and risk-stratified chemotherapeutic approaches have led to dramatic 
improvements in survival rates for many childhood cancers (Smith & Ries, 2002; Ries, 
Eisner & Kosary, 2003; Linabery & Ross, 2008). These same cancer therapies are also 
thought to be responsible for many neurocognitive, metabolic, and cardiovascular 
complications experienced by survivors post-treatment (Oeffinger et al., 2006). 
Although free of cancer, many childhood cancer survivors (CCS) are plagued by a 
higher incidence of abnormal growth and development (Gurney et al., 2003), endocrine 
disorders (Nandagopal et al., 2008), premature cardiovascular disease (CVD) and 
cerebrovascular disease (Mertens et al., 2001; Oeffinger et al., 2001; Bowers et al., 2006; 
Mulrooney et al., 2009), as well as declines in neurocognitive function (Moleski, 2000; 
Kaemingk et al., 2004; Anderson & Kunin-Batson, 2009). Indeed, many adult survivors 
of childhood cancer are at seven times the risk of dying from CVD compared to the 
general population (Mertens et al., 2001; Mertens, 2007). Most of the increased risk is 
thought to be the result of the therapies used to treat the cancer, such as chemotherapy 
and radiation. These therapies likely cause damage to the endothelial cells, which line the 
arterial wall and, when functioning properly, offer protection from atherosclerosis 
(Lüscher & Barton, 1997; Kinlay, Libby, & Ganz, 2001; Drexler, 1998; Halcox & 
Deanfield, 2004). Research has demonstrated that young adult survivors of childhood 
acute lymphoblastic leukemia (ALL) have endothelial dysfunction compared to healthy 
controls approximately 20-years after receiving cancer treatment (Dengel et al., 2008; 
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Dengel et al., 2014). Additionally, adult survivors of childhood ALL have reduced 
carotid compliance and distensibility, indicators of arterial stiffness, compared to healthy 
sibling controls (Dengel et al., 2014). Endothelial dysfunction and arterial stiffness are 
considered early manifestations of atherosclerosis and therefore may be ideal targets of 
therapy to reduce CVD risk (Celermajer et al., 1992; Deanfield et al., 2007). 
HMG coenzyme A reductase inhibitors, or statins, are widely used for 
cardiovascular disease risk reduction because of their ability to lower circulating low-
density lipoprotein (LDL) cholesterol and triglycerides (Stone et al., 2013). However, 
there are multiple cholesterol-independent beneficial pleiotropic effects of statins on 
vascular health (Reriani et al., 2011), including: (1) up-regulation of endothelial nitric 
oxide synthase resulting in increased production of nitric oxide (Matsuno et al., 2004; Ota 
et al., 2010); (2) inhibition of arterial smooth muscle cell proliferation (Axel et al., 2000); 
(3) reduction of arterial stiffness (Orr et al., 2009; Ratchford et al., 2011); (4) 
inflammation (Ridker et al., 2008); and (5) oxidative stress (Suzumura et al., 1999; 
Rikitake et al., 2001; Singh et al., 2008). Therefore, statin treatment, independent of 
cholesterol lowering, may improve endothelial function and other aspects of vascular 
health in young adult CCS, which could mitigate the medium- and long-term risk of 
developing CVD. 
Despite the potential for improved vascular health and reduced CVD risk, to our 
knowledge, statin therapy has never been evaluated in young adult CCS. Therefore, the 
primary objective of this pilot clinical trial was to assess the ability of atorvastatin to 
improve brachial artery endothelial function (primary endpoint) and other aspects of 
vascular health including small artery endothelial function, regional arterial stiffness, and 
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carotid artery elasticity and thickening in young adult CCS over a 6-month treatment 
period. The focus of the trial was on survivors of hematologic malignancies, ALL and 
Non-Hodgkin’s lymphoma (NHL), as studies have shown ALL to be associated with 
endothelial impairments and because both ALL and NHL survivors share common 
treatment exposures (chemotherapy and radiation). We hypothesized that, compared to 
placebo, atorvastatin would significantly increase brachial artery endothelial function, 
small artery endothelial function, and carotid artery elasticity, as well as reduce arterial 
thickness, in young adult survivors of ALL and NHL. 
 
MATERIALS AND METHODS 
The study protocol was approved by the University of Minnesota Institutional 
Review Board (IRB) and the Children’s Hospitals and Clinics of Minnesota IRB. All 
participants provided informed consent for study participation. All testing was performed 
at the University of Minnesota Clinical and Translational Science Institute 
(NCT01733953). 
 
Study Population 
Twenty-seven young adult survivors of childhood ALL or NHL were recruited to 
participate in the randomized, double-blind, placebo-controlled, pilot clinical trial. Due to 
historical treatment heterogeneity among Hodgkin’s lymphoma and NHL survivors, adult 
survivors of childhood Hodgkin’s lymphoma were not recruited in the present trial. 
Inclusion criteria included being between the ages of 18 and 39 years old, having been 
treated for cancer before 21 years of age, and being ≥5-yrs post-treatment. 
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Randomization was stratified by receipt of hematopoietic stem cell transplantation (i.e. 
bone marrow transplant). Initial exclusion criteria included: prior bone marrow transplant 
(BMT); Type 1 or Type 2 diabetes mellitus; LDL-cholesterol ≥130 mg/dL; alanine 
transaminase (ALT), aspartate transaminase (AST), or creatine kinase (CK) values >2x 
the upper limit of normal; current or recent (within 6 months) use of lipid-lowering 
medication; recent initiation (within 6 months) of anti-hypertensive medication 
(participants on stable therapy were allowed to enroll); current or recent (within 6 
months) use of fibric acid derivatives, lipid-modifying doses of niacin, cyclosporine or 
strong CYP3A4 inhibitors (i.e. clarithromycin, HIV protease inhibitors, and 
itraconazole); and females who were pregnant or planning to become pregnant. 
Individuals with elevated LDL-cholesterol were referred for clinical management of 
dyslipidemia. Exclusion criteria were relaxed approximately halfway through enrollment 
to include both survivors treated with a BMT in attempts to combat low enrollment. To 
further combat low recruitment, LDL exclusion at baseline was also relaxed to ≤160 
mg/dL (originally ≤130 mg/dL) to reflect the 2013 ACC/AHA Guidelines on the 
Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 
(Stone et al., 2014). 
Eligible participants were recruited from the childhood Cancer Survivorship 
Program (cCSP) at the University of Minnesota and Children’s Hospitals and Clinics of 
Minnesota from 2013-2014 with follow-up lasting until early 2015. Enrollment was 
ceased once recruit goal and study timeline were met.  
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Experimental Design and Protocol 
Baseline measurements were conducted following initial screening of inclusion 
and exclusion criteria. Family and personal history, current medical status, and current 
medication usage were assessed, along with anthropometrics, urine pregnancy test 
(females), metabolic panel, and vascular function, structure, and mechanical 
measurements. Cancer diagnosis and specific treatment details were obtained from 
medical chart extraction. 
Following baseline measurements, the Investigational Drug Services (IDS) at the 
University of Minnesota used the Web site Randomization.com to generate the permuted-
block randomization scheme (blocks of 4 and 1:1 allocation ratio). Participants were 
randomized in a double-blind manner to receive 40 mg of atorvastatin once daily or 
matched placebo for 6 months. Participants returned at 1 month and 3 months for safety 
assessments (blood draw and adverse event review) and at 6 months for assessment of 
safety and follow-up vascular assessment. Anthropometric measurements were obtained 
at each visit. Participants were asked to fast for a minimum of 12 hours prior to the 
baseline and 6-month visits. Phone calls were conducted at 2, 4, and 5 months to review 
interim medical history, changes in concomitant medication, as well as assess adverse 
events. Participants were instructed to take each dose in the evening along with food. 
Drug compliance was assessed by counting the number of pills returned at each study 
visit. 
 A data and safety review was conducted after approximately half of participants 
were enrolled, and at the end of the trial. Also, at any given time throughout the study, 
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the trial was to be stopped if more than 25% of subjects were withdrawn due to elevated 
enzyme levels. Trial stoppage due to withdrawal did not occur. 
 
Anthropometric and Clinical Assessments 
Measurements for height and weight were obtained with an electronic scale (ST 
Scale-Tronix, Model 5002, White Plains, NY, USA) with participants in light clothing, 
without shoes. Body mass index (BMI) was calculated as weight in kilograms divided by 
height in meters-squared. Seated blood pressure and heart rate were measured three 
consecutive times via automated sphygmomanometer at approximately 3-minute intervals 
on the right arm following 10-minute of quiet rest. The final two measurements were 
averaged and used for analysis. Fasting blood samples were obtained for lipids and 
plasma glucose (analyzed with standard procedures at the Fairview-University Medical 
Center clinical laboratory).  
 
Vascular Assessments 
Testing was performed in the Vascular Biology Laboratory in the University of 
Minnesota Clinical and Translational Science Institute. All the vascular studies were 
performed in a quiet, temperature-controlled environment (22-23°C). Participants had 
fasted for a minimum of 12 hours prior to both baseline and 6-month vascular 
assessments and were also asked to abstain from caffeine ingestion or cigarette smoking. 
Baseline vascular assessment was prioritized for the morning hours (between 8:00 AM 
and 11:00 AM), and 6-month testing was required to be within ±2 hours of the time of 
day when baseline testing was assessed.  
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Endothelial Function 
Flow-Mediated Dilation (FMD). Following 15 minutes of quiet rest in the supine 
position, vascular images of the left brachial artery at the distal third of the upper arm 
was obtained using a conventional ultrasound scanner (Siemens, Sequoia 512, Mountain 
View, CA, USA) with a 10.0 MHz linear array probe held at a constant distance from the 
skin and at a fixed point over the brachial artery by a stereotactic arm (Celermajer et al., 
1992). Brachial artery blood flow was determined by pulse-wave Doppler (HSS = 
8*0.035*systolic flow velocity / diameter). Following baseline measurements of the 
brachial artery, a blood pressure cuff was placed on the forearm (distal to the imaged 
area) and inflated to a suprasystolic level for 5 minutes. The change in brachial artery 
blood flow and diameter was measured by B-mode ultrasound imaging for 3 minutes 
after cuff release. Peak dilation during the study was defined as the greatest percent 
change from resting brachial artery diameter, while area under the curve (AUC) was 
defined as the total relaxation of the brachial artery from resting baseline following 
reactive hyperemia or sublingual nitroglycerin administration. Intra-individual 
reproducibility of FMD within our laboratory has been demonstrated as a mean 
difference of 0.53±0.28%. Images were digitized and stored on a personal computer for 
later off-line analysis with an electronic wall-tracking software program (Vascular 
Research Tools 5, Medical Imaging Application, LLC, Coralville, IA, USA). 
 Digital Reactive Hyperemia Index (RHI). Reactive hyperemia (EndoPAT2000, 
Itamar Medical, Caesarea, Israel) was simultaneously measured alongside FMD 
assessment. After 10 minutes of quiet rest in the supine position (and 5 minutes prior to 
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FMD), one peripheral arterial tonometry (PAT) finger probe was placed on the index 
finger of the left hand undergoing hyperemia testing, and a second PAT probe was placed 
on the contralateral index finger (right). Both probes inflate to apply a uniform pressure 
on the fingers (10 mmHg less than diastolic blood pressure) and detect small pulse 
volume changes throughout the cardiac cycle. Following 5 minutes of baseline data 
collection, a blood pressure cuff on the upper left forearm (just below the elbow) was 
inflated to a suprasystolic level for 5 minutes. Following cuff release, the change in pulse 
amplitude during reactive hyperemia was measured for 5 minutes. The ratio of the 
hyperemic and the baseline pulse amplitude (corrected for the same ratio on the control 
finger, thereby controlling for autonomic tone due to vasoconstriction and transient 
environmental effects) was calculated and expressed as the reactive hyperemic index 
(RHI).  
 
Artery Elasticity and Thickness 
Carotid artery images were obtained by a non-invasive ultrasound scanner 
(Siemens, Sequoia 512, Mountain View, CA, USA) with a 10.0 MHz linear array probe. 
Following 15 minutes of quiet rest in the supine position, luminal systolic and diastolic 
diameters were obtained at a fixed point over the left common carotid artery, 
approximately 1 centimeter proximal from the carotid bulb. Images were collected at 20 
frames per second for 10 seconds (200 frames) to ensure the capture of full arterial 
diameter change during a cardiac cycle. Systolic and diastolic blood pressures were 
recorded with an automated blood pressure sphygmomanometer during the 10-second 
carotid measurement. The mean diameter through the 10-second cycle was used to 
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calculate measures of elasticity, specifically carotid compliance and distensibility. 
Carotid artery intima-media thickness (cIMT) measures were also obtained using the 
same technique. The ultrasound scanning system was interfaced with a standard personal 
computer equipped with a data acquisition card for attainment of radio frequency 
ultrasound signals from the scanner. Digital image analysis was performed by the same 
trained reader blinded to group assignments. The following formulas for carotid artery 
compliance and distensibility were used: 
• Diameter distensibility (DD, %): [∆D / Dmin] x 100% 
• Cross-sectional distensibility (CSD, %): [(π*(Dmax/2)2 - 
π*(Dmin/2)2)/π*(Dmin/2)2] x 100% 
• Diameter compliance (DC, mm/mmHg): ∆D / ∆P 
• Cross-sectional compliance 1 (CSC1, mm2/mmHg): [(π*(Dmax/2)2 - 
π*(Dmin/2)2)/(∆P)] 
• Cross-sectional compliance 2 (CSC2, 1/mmHg): [(π*(Dmax/2)2 - 
π*(Dmin/2)2)/(π*(Dmin/2)2*∆P)] 
• Incremental elastic modulus (IEM, mmHg): 3{1+[π*(maxDiamM/2)2/ 
π*(minDiamM/2)2]} / CSC1 
Pulse pressure (∆P) was calculated as the difference between systolic and 
diastolic pressures. Diameter change (∆D) was calculated as the difference in arterial 
diameter at systolic and diastolic pressures. Additionally, Dmax denotes maximum 
diameter, and Dmin denotes minimum diameter. 
Regional arterial stiffness was also measured non-invasively by carotid-radial 
pulse wave velocity (PWV) and aortic augmentation index (AI) (SphygmoCor® system, 
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Sydney, Australia). Carotid-radial PWV and aortic AI were derived by automated 
algorithms from pressure waveforms obtained by lightly applying a tonometer to the skin. 
AI is a measure of the relative magnitude of the reflected (or retrograde) pulse wave early 
in the cardiac cycle. PWV is calculated as distance (m) / transit time (s). The distance was 
measured between the carotid and radial sites and the sternal notch. The SphygmoCor® 
system measures the time between the R-wave of the electrocardiogram (ECG) and the 
feet of the pressure and distension wave respectively at the site of measurement. Higher 
values of AI and PWV represent increased arterial stiffening. 
 
Sample Size Determination 
Our goal was to collect preliminary data to determine the treatment effect and 
variability estimates to inform the design of a larger clinical trial. Our choice of sample 
size (n=26) was based upon the number of participants that could be feasibly enrolled in a 
one-year period and the amount of funding available.  
 
Statistical Analysis 
 SAS Software Package (Version 9.2, 2009, SAS Inc., Cary, NC, USA) was used for 
statistical analyses. Baseline results are expressed as mean±standard deviation (SD), 
unless otherwise stated. The primary analysis was performed on a per-protocol 
population, which included participants with a treatment compliance level of ≥70% of 
expected doses. An intent-to-treat analysis was also performed on all randomized 
participants who completed all 6 months of the study according to treatment assignment.  
 A generalized linear model was used to assess per-protocol treatment effect on 
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vascular health outcome changes at 6 months (i.e. difference between 6-month and 
baseline), adjusted for individual baseline values (Frison & Pocock, 1992; Senn, 2006). 
Mean differences (with 95% confidence intervals) from baseline were also calculated for 
each treatment group. Brachial artery peak FMD was the primary vascular outcome of 
interest. Secondary vascular outcome measures were RHI, carotid-radial PWV, aortic AI 
measured via carotid and radial sites, and carotid artery elasticity and thickness. An alpha 
value of 0.05 was used to signify statistical significance. 
 
RESULTS 
Twenty-seven participants (mean age 26.8±6.2 years; 14 male, 13 female) were 
randomized. Figure 1 shows participant flow and disposition (CONSORT diagram). 
Mean baseline demographic, clinical, and vascular characteristics are presented in Tables 
1 and 2 for all randomized participants. 
Per-protocol treatment effects on vascular outcome changes at 6 months, along 
with mean differences from baseline by treatment group, are displayed in Table 3. No 
significant treatment effects were observed for any primary or secondary vascular 
outcome measures. Specifically, treatment effect on peak FMD and RHI was 2.3 [95% 
CI: -0.4 to 5.0; P=0.090] and 0.37 [95% CI: -0.05 to 0.80; P=0.083], respectively. Similar 
results were observed in the intent-to-treat analysis.  
 Of the 14 participants randomized to atorvastatin, 5 participants were not used in 
the per-protocol analysis. Specifically, physician withdrawals (n=3), loss to follow-up 
(n=1), and drug compliance <70% (n=1) resulted in 9 atorvastatin-randomized 
participants analyzed. Of the 13 participants randomized to placebo, 7 participants were 
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not used in the analysis with physician withdrawals (n=3), loss to follow-up (n=1), 
unrelated injury (n=1), and self-withdrawal (n=2) resulting in 6 placebo-randomized 
participants analyzed. Additionally, participant movement during FMD assessment 
and/or poor ultrasound image quality due to difficult brachial artery anatomy or poor 
circulation led to some unusable data and thus lowered the analyzable sample size. 
 A summary of cumulative adverse events by treatment group is displayed in Table 
4. Abnormal safety labs included all instances where an elevated safety blood draw 
(ALT, AST, or CK) required additional follow-up beyond protocol requirements. 
Miscellaneous adverse events included reports of headache, insomnia, dizziness, rash, 
urinary tract infection, etc. Total drug compliance was not significantly different between 
atorvastatin and placebo groups (86.1±11.4 vs. 82.9±10.7%, P=0.587), respectively.  
 
DISCUSSION 
 To our knowledge, this is the first trial to evaluate the effect of atorvastatin on 
arterial health in adult survivors of childhood cancer. While the vascular benefits of statin 
therapy in different patient populations are well documented, atorvastatin did not 
significantly improve arterial health compared to placebo in this trial of young adult 
survivors of childhood cancer. Unfortunately, the very small number of evaluable 
participants who completed follow-up limits our ability to draw confident and meaningful 
conclusions regarding the effect of atorvastatin on artery health in young adult CCS. 
Indeed, conservative management of adverse events by the study physician led to higher 
withdrawal than originally anticipated. Additionally, loss to follow-up, self-withdrawal 
due to time commitment, and poor ultrasound image quality due to participant movement, 
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difficult brachial artery anatomy, or poor circulation further contributed to a smaller 
analyzable sample size. 
 A recent meta-analysis of 46 randomized controlled trials has demonstrated that 
statin therapy improves endothelial function, as assessed by FMD [standardized mean 
difference 0.68 (95% CI: 0.46 to 0.90; P< 0.001)], as well as venous occlusion 
plethysmography and coronary infusion of acetylcholine, in a wide array of populations 
(Reriani et al., 2011). Additional studies in overweight and obese adults have also 
reported arterial de-stiffening with 80 mg/day of atorvastatin following 30 days 
(Ratchford et al., 2011) and 12-weeks (Orr et al., 2009) of treatment. In the present study, 
however, we did not observe such an effect. 
 Aside from a small analyzable sample size, another possible factor that may have 
influenced our findings was the inconsistent time of day that vascular testing was 
performed. Early morning testing was not always a viable option for participants due to 
conflicting work schedules or longer commutes. Endothelial function is influenced by 
diurnal variation. Indeed, both in asymptomatic participants and those with established 
cardiovascular disease, peak FMD is lower in the morning compared with other times of 
day (Bau et al., 2008; Kollias et al., 2009; Otto et al., 2004), which may be the result of 
acute increases in augmented sympathetic activation (Muller et al., 1995; Hijmering et 
al., 2002), hemodynamic changes (Panza et al., 1991), neuro-hormonal factors and 
increases in coagulation (Tofler et al., 1987) shortly after waking. Similar findings of 
increased arterial stiffness via pulse wave analysis have been reported in the morning 
hours (Papaioannou et al., 2006; Bodlaj et al., 2007).  
 There were several limitations of the present trial. While we exceeded our 
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recruitment goal, the number of participants with complete data in each treatment group 
was much smaller than expected due to early withdrawal/termination, loss to follow-up, 
and inability to analyze some of the vascular images due to poor image quality (e.g. 
arterial nodules, poor circulation). Second, the time of day when the daily dose was taken 
was not always in the evening (as recommended). While a meta-analysis of 164 trials 
examining the effect of statins on LDL-lowering reported average LDL-cholesterol 
reduction of 3.6 mg/dL smaller with morning vs. evening dosing (Law et al., 2003), 
statins like atorvastatin and rosuvastatin have longer half-lives and avoid the timing of 
peak synthesis problem. Specifically, Cilla et al. (1996) reported similar lipid changes 
with atorvastatin in both morning and evening doses. Third, we did not measure statin 
concentration in the blood or urine directly to assess drug compliance. And finally, given 
that CVD outcomes among CCS vary by cancer severity, treatment modalities, sex, age at 
treatment and number of years since treatment (Shankar et al., 2008; Buizer et al., 2005; 
van der Pal et al., 2010), future trials should strive to achieve a sufficient sample size to 
allow for stratification by these factors. 
 
CONCLUSION 
 Within the context of this small pilot clinical trial, 6 months of atorvastatin 
treatment did not significantly improve endothelial function, regional arterial stiffness, or 
carotid elasticity and structure, compared to placebo. However, the present trial results 
should be interpreted with caution owing to the small sample size. A larger pilot clinical 
trial is warranted before moving to a full-scale study.   
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Table 1. Baseline Demographic and Clinical Characteristics for All Randomized Participants 
 
 
Mean (SD) 
Overall 
(N=27) 
Randomized Completed 6-Month Follow-Up 
Atorvastati
n (n=14) 
Placebo 
(n=13) 
Atorvastatin 
(n=9) 
Placebo 
(n=6) 
Age (years) 26.8 (6.2) 26.6 (5.7) 26.9 (6.9) 28.0 (5.7) 26.4 (7.5) 
Sex (Male), n (%) 14 (51.9%) 6 (42.9%) 8 (61.5%) 3 (33.3%) 3 (50.0%) 
White Race, n (%) 27 (100%) 14 (100%) 13 (100%) 9 (100%) 6 (100%) 
Latino/Hispanic, n(%) 1 (3.7%) 0 (0%) 1 (7.7%) 0 (0%) 1 (16.7%) 
Current Smokers, n(%) 1 (3.7%) 1 (7.1%) 0 (0%) 1 (11.1%) 0 (0%) 
Diagnosis Age (years) 7.2 (5.2) 8.0 (4.6) 6.2 (5.8) 7.8 (3.9) 5.0 (3.2) 
Years Cancer Free 
(years) 17.1 (7.3) 16.1 (6.6) 18.2 (8.1) 17.9 (7.3) 18.4 (7.6) 
Cancer Diagnosis, n(%)      
   ALL 19 (70.4%) 10 (71.4%) 9 (69.2%) 6 (66.7%) 5 (83.3%) 
   NHL 8 (29.6%) 4 (28.6%) 4 (30.8%) 3 (33.3%) 1 (16.7%) 
Cancer Treatment, 
n(%)    
  
   Chemotherapy 17 (63.0%) 9 (64.3%) 8 (61.5%) 5 (55.6%) 4 (66.7%) 
   Chemo + Rad 9 (33.3%) 4 (28.6%) 5 (38.5%) 4 (44.4%) 2 (33.3%) 
   BMT 1 (3.7%) 1 (7.1%) 0 (0%) 0 (0%) 0 (0%) 
Weight (kg) 88.3 (22.1) 89.5 (22.8) 87.0 (22.1) 91.6 (21.5) 72.5 (12.3) 
Height (cm) 169.1 (11.7) 168.1 (10.0) 170.2 (13.6) 165.5 (10.9) 169.6 (12.8) 
BMI (kg/m2) 31.0 (7.5) 31.8 (7.9) 30.1 (7.3) 33.6 (7.9) 25.4 (4.8) 
SBP (mmHg) 124.2 (14.5) 119.4 (13.3) 129.4 (14.4) 119.0 (14.9) 121.3 (14.2) 
DBP (mmHg) 69.7 (11.9) 67.5 (10.1) 72.2 (13.7) 66.8 (11.6) 69.2 (12.3) 
Heart Rate (bpm) 67.8 (10.0) 68.8 (7.6) 66.8 (12.3) 69.4 (8.4) 64.7 (11.3) 
Fasting Glucose 
(mg/dL) 79.9 (16.7) 83.9 (10.7) 75.1 (20.9) 84.0 (10.5) 69.5 (30.5) 
TC (mg/dL) 174.0 (34.9) 175.9 (40.8) 171.9 (28.9) 190.6 (33.1) 167.3 (26.9) 
LDL (mg/dL) 104.0 (31.5) 105.2 (34.0) 102.8 (29.8) 119.4 (25.3) 97.5 (36.1) 
VLDL (mg/dL) 23.1 (9.0) 25.4 (9.7) 20.6 (7.9) 28.0 (8.6) 18.5 (6.8) 
HDL (mg/dL) 46.8 (10.8) 45.2 (10.2) 48.5 (11.6) 43.0 (9.1) 51.2 (13.8) 
Triglycerides (mg/dL) 115.6 (44.6) 127.0 (48.0) 103.3 (38.8) 140.3 (43.3) 93.5 (33.1) 
TC/HDL Ratio 3.9 (1.1) 4.0 (1.2) 3.7 (1.1) 4.5 (1.0) 3.6 (1.3) 
ALT (U/L) 38.7 (16.2) 36.9 (15.3) 40.7 (17.5) 34.6 (11.6) 27.5 (8.2) 
AST (U/L) 29.5 (10.4) 27.4 (11.8) 31.9 (8.5) 26.9 (9.4) 24.8 (2.4) 
CK (U/L) 107.4 (53.9) 104.2 (61.6) 110.9 (47.7) 93.7 (54.6) 99.7 (15.9) 
Results expressed as Mean (SD) or n (%) where indicated. Abbreviations: ALL, acute lymphoblastic 
leukemia; NHL, Non-Hodgkin’s lymphoma; BMT, bone marrow transplant; BMI, body mass index; SBP, 
systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL, low-density 
lipoproteins; VLDL, very low-density lipoproteins; HDL, high-density lipoproteins; ALT, alanine 
transaminase; AST, aspartate aminotransferase; CK, creatine kinase. 
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Table 2. Baseline Vascular Characteristics for All Randomized Participants 
 
All Randomized 
(n=27) 
Atorvastatin 
(n=14) 
Placebo  
(n=13) 
n Mean(SD) n Mean (SD) n Mean(SD) 
Brachial Artery Ultrasound 
  Peak FMD (%) 22 6.7(3.7) 12 6.7(3.4) 10 6.7(4.2) 
EndoPAT 
  RHI (%) 25 1.90(0.47) 12 2.05(0.47) 13 1.76(0.45) 
  AI (%) 25 -7.64(9.76) 12 -6.62(11.72) 13 -8.59(7.92) 
Carotid Artery Ultrasound 
  cIMT (mm) 23 0.55(0.05) 13 0.56(0.04) 10 0.55(0.06) 
  cDD (%) 25 9.58(2.28) 14 9.58(2.65) 11 9.58(1.84) 
  cCSD (%) 25 20.13(5.02) 14 20.15(5.83) 11 20.11(4.05) 
  cDC (mm/mmHg x 10-3) 25 11.3(2.5) 14 11.7(3.0) 11 10.8(1.6) 
  cCSC1 (mm2/mmHg x 10-3) 25 120.7(28.5) 14 124.2(35.2) 11 116.2(17.3) 
  cCSC2 (1/mmHg x 10-3) 25 3.7(0.9) 14 3.8(1.1) 11 3.5(0.6) 
  cIEM (mmHg) 25 1527.4(421.6) 14 1484.1(444.3) 11 1582.6(404.9) 
SphygmoCor 
  PWV (m/s) 26 7.9(2.0) 14 8.1(2.5) 12 7.6(1.0) 
  Carotid AI (P2/P1) 18 116.8(19.2) 9 121.8(23.0) 9 111.8(14.3) 
  Radial AI (P2/P1) 25 119.0(25.4) 13 118.8(32.4) 12 119.2(16.5) 
Results expressed as Mean (SD) or n (%) where indicated. All reported brachial and carotid artery 
measurements performed on the left brachial artery and left common carotid artery. “c” denotes 
carotid artery assessment. Abbreviations: FMD, flow-mediated dilation; RHI, reactive hyperemia 
index; AI, augmentation index; IMT, intima-media thickness; DD, diameter distensibility; CSD, cross-
sectional distensibility; DC, diameter compliance; CSC1, cross-sectional compliance 1; CSC2, cross-
sectional compliance 2; IEM, incremental elastic modulus; PWV, pulse wave velocity. 
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Table 3. Per-Protocol Treatment Effect of Atorvastatin Therapy on Vascular Health 
Outcome 
Variables 
Mean Difference [95% CI]  
from Baseline Treatment Effect 
n Atorvastatin n Placebo n Difference (Ref=Placebo) 
95% CI P-
value LL UL 
Brachial Artery Ultrasound 
FMD Peak 
Dilation (%) 8 
-0.5  
[-2.9, 1.9] 3 
-3.4  
[-7.3, 0.6] 11 2.3 -0.4 5.0 0.090 
EndoPAT 
RHI (%) 9 -0.12  [-0.52, 0.28] 6 
-0.01  
[-0.51, 0.48] 15 0.37 -0.05 0.80 0.083 
AI (%) 9 -2.92  [-10.44, 4.60] 6 
7.56  
[-1.65, 16.77] 15 -7.12 -18.77 4.52 0.230 
Carotid Artery Ultrasound 
cIMT (mm) 9 -0.01  [-0.03, 0.01] 5 
0.01  
[-0.02, 0.04] 14 0.002 -0.038 0.042 0.922 
cDD (%) 9 0.14  [-0.60, 0.87] 5 
0.14  
[-0.84, 1.12] 14 0.052 -1.137 1.240 0.932 
cCSD (%) 9 0.31  [-1.28, 1.90] 5 
0.33  
[-1.81, 2.47] 14 0.116 -2.469 2.702 0.930 
cDC (mm/mmHg 
x10-3) 9 
-0.34  
[-1.4, 0.7] 5 
0.57  
[-0.8, 2.0] 14 -0.9 -2.66 0.858 0.315 
cCSC1 
(mm2/mmHgx10-3) 9 
-1.6  
[-14.01, 10.81] 5 
8.94  
[-7.71, 25.59] 14 -9.71 -31.07 11.65 0.373 
cCSC2 (1/mmHg 
x 10-3) 9 
-0.00222  
[-0.39, 0.382] 5 
0.18  
[-0.34, 0.695] 14 -0.19 -0.82 0.454 0.570 
cIEM (mmHg) 9 146.4  [-103.2, 396.0] 5 
99.6  
[-235.3, 434.4] 14 46.6 -372.4 465.6 0.827 
SphygmoCor 
PWV (m/s) 9 -0.52  [-2.06, 1.02] 5 
-0.30  
[-2.36, 1.76] 14 0.76 -0.871 2.397 0.360 
Carotid AI (P2/P1) 6 -0.66  [-15.38, 14.06] 4 
-6.01  
[-24.16, 12.15] 10 5.35 -18.43 29.13 0.659 
Radial AI (P2/P1) 9 6.74  [-5.64, 19.13] 5 
-8.34  
[-25.29, 8.61] 14 15.09 -6.56 36.73 0.172 
Per-Protocol Analysis (≥70% drug compliance) was performed on both treatment groups. Participant data was 
not included as part of per-protocol analysis if participant did not finish the trial or had insufficient or 
uninterpretable data. All reported brachial and carotid artery measurements performed on the left brachial 
artery and left common carotid artery. “c” denotes carotid artery assessment. FMD, flow-mediated dilation; 
RHI, reactive hyperemia index; AI, augmentation index; IMT, intima-media thickness; DD, diameter 
distensibility; CSD, cross-sectional distensibility; DC, diameter compliance; CSC1, cross-sectional compliance 
1; CSC2, cross-sectional compliance 2; IEM, incremental elastic modulus; PWV, pulse wave velocity. 
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Table 4. Intent-to-Treat Summary of Cumulative Adverse Events (AE) by 
Treatment Group for All Randomized Participants 
AE Categories 1-Month Visit 3-Month Visit 6-Month Visit 
Atorvastatin (n=14) 
Musculoskeletal 3 (21%) 5 (36%) 6 (43%) 
Gastrointestinal 3 (21%) 3 (21%) 3 (21%) 
Fatigue 0 (0%) 1 (7%) 1 (7%) 
Cognitive  0 (0%) 0 (0%) 0 (0%) 
Abnormal Safety Labs 3 (21%) 3 (21%) 3 (21%) 
Respiratory 3 (21%) 7 (50%) 8 (57%) 
Miscellaneous 4 (29%) 8 (57%) 11 (79%) 
 Placebo (n=13) 
Musculoskeletal 0 (0%) 3 (23%) 4 (31%) 
Gastrointestinal 2 (15%) 2 (15%) 3 (23%) 
Fatigue 1 (8%) 2 (15%) 2 (15%) 
Cognitive  1 (8%) 2 (15%) 2 (15%) 
Abnormal Safety Labs  4 (31%) 4 (31%) 4 (31%) 
Respiratory 2 (15%) 5 (38%) 6 (46%) 
Miscellaneous 2 (15%) 4 (31%) 6 (46%) 
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Figure 1. Consort Diagram 
!
!
Assessed for Eligibility (n=875) 
Potentially Eligible (n=523) 
Eli 
• Not meeting inclusion/exclusion criteria, 
inaccurate/outdated contact information 
(n=352) 
• Returned letters, no response (n=475) 
• Agreed to participate, but later refused (n=13) 
• Could not participate due to confounding 
medication/vascular disorder (n=4) 
• Failed screen (n=4) 
 
Atorvastatin (n=14) 
!
Physician withdrew (n=3) 
Lost to follow-up (n=1) 
Unrelated injury (n=1) 
Withdrew self (n=2) 
Placebo (n=13) 
Analysed (n=6) 
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FOLLOW-UP 
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Randomized (n=27) 
Physician withdrew (n=3) 
Lost to follow-up (n=1) 
Drug compliance <70% (n=1) 
 
Analysed (n=9) 
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Research Results and Implications 
Non-invasive assessment of carotid arterial elasticity and stiffness has been 
extensively studied over the past several decades. While there appears to be a reliable 
relationship between risk factors such as advanced aging and hypertension with 
decreased arterial elasticity and increased stiffness, studies of carotid arterial elasticity in 
otherwise healthy populations are lacking. The present dissertation offers a more detailed 
understanding of arterial elasticity and stiffness and how to non-invasively assess carotid 
artery mechanics detailed in three separate studies with one common theme. The main 
findings of the three studies presented in this dissertation demonstrate the ease and 
feasibility of accurately assessing carotid artery elasticity and stiffness, as well as extends 
previous knowledge age and sex differences in healthy adolescents and adults. 
First, carotid artery elasticity in children and adolescents was assessed and 
differences between pubertal stages were evaluated. Results indicated that carotid artery 
elasticity did not differ significantly throughout pubertal development and that 
accounting for pubertal stage when reporting vascular data in children and adolescents 
may be unnecessary. Vascular elasticity and stiffness impairment is more prevalent with 
increasing age and thus, evaluating differences in carotid artery elasticity and stiffness in 
otherwise healthy youth may not be a sensitive enough measure for detecting vascular 
dysfunction. Indeed, pubertal stage and the cardiometabolic risk factors associated with 
puberty (specifically insulin resistance mid-puberty) did not seem to affect vascular 
mechanics in our study. 
 Second, carotid artery elasticity in both adolescents and adults was assessed and 
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examined for sex differences. Results indicated that adolescent males and females did not 
significantly differ with respect to carotid artery elasticity measures. Conversely, adult 
females had significantly greater cross-sectional compliance compared to males. While 
the exact mechanisms for the sex difference observed in adults is not clear, a greater 
supine pulse pressure observed in males in addition to a possible greater overall vessel 
distention in females may explain part of the observation. Interestingly, significant 
correlations between brachial and carotid artery measures of elasticity were more 
common among youth than in adults. Indeed, vascular remodeling increases with age and 
may explain the divergent relationship between nearby vascular beds in adults. 
 And finally, the effect of 6-months of atorvastatin on carotid artery elasticity and 
stiffness was assessed in a group of adult survivors of childhood cancer in the third and 
final study. While the results of this study indicate that a low-dose of atorvastatin does 
not improve carotid elasticity and stiffness compared to placebo, results should be 
interpreted with caution due to the small number of evaluable participants. Nonetheless, 
this was a groundbreaking study to examine the feasibility of conducting such a trial in 
adult survivors of childhood cancer. Indeed, recruitment and execution of studies in 
cancer survivors are particularly difficult due to low patient retention and general lack of 
willingness to participate. 
This dissertation establishes an argument that measures of carotid artery elasticity 
lacks differentiation throughout development in youth, yet sex differences in carotid 
elasticity may become more apparent in adulthood. While inconclusive, atorvastatin did 
not improve carotid artery elasticity compared to controls as previously hypothesized.  
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Future Research 
 While this dissertation demonstrates that sex and pubertal stage differences may 
not be different otherwise healthy youth, future studies should continue to gather these 
measures to confirm these findings. Specifically, longitudinal studies examining carotid 
artery elasticity should be employed in youth to determine possible risk factors that 
contribute to possible differences seen in adulthood. Additionally, future studies in higher 
risk youth should also be engaged to better understand physiologic differences in vascular 
remodeling under such conditions. 
 While findings in the atorvastatin trial were difficult to confidently interpret, the 
primary goal of the study was to assess trial feasibility and estimate a treatment effect for 
future studies wanting to expand on the effect of statin therapy on vascular function. 
Indeed, our treatment effect indicates that a much larger sample size is needed to 
adequately answer the question of whether atorvastatin can improve vascular function, 
structure, and mechanics. 
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